US20020029051A1 - Occluding device and method of use - Google Patents

Occluding device and method of use Download PDF

Info

Publication number
US20020029051A1
US20020029051A1 US09/468,749 US46874999A US2002029051A1 US 20020029051 A1 US20020029051 A1 US 20020029051A1 US 46874999 A US46874999 A US 46874999A US 2002029051 A1 US2002029051 A1 US 2002029051A1
Authority
US
United States
Prior art keywords
tubular member
lumen
mesh
body lumen
contraceptive
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
US09/468,749
Other versions
US6432116B1 (en
Inventor
Jeffrey Callister
William Tremulis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Healthcare LLC
Original Assignee
Edward J. Lynch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edward J. Lynch filed Critical Edward J. Lynch
Priority to US09/468,749 priority Critical patent/US6432116B1/en
Priority to US09/911,551 priority patent/US20010041900A1/en
Publication of US20020029051A1 publication Critical patent/US20020029051A1/en
Publication of US6432116B1 publication Critical patent/US6432116B1/en
Application granted granted Critical
Priority to US11/116,480 priority patent/US20050217680A1/en
Assigned to AMS RESEARCH CORPORATION reassignment AMS RESEARCH CORPORATION MERGER (SEE DOCUMENT FOR DETAILS). Assignors: OVION, INC.
Assigned to CONCEPTUS, INC. reassignment CONCEPTUS, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: AMS RESEARCH CORPORATION
Assigned to WELLS FARGO BANK, NATIONAL ASSOCIATION reassignment WELLS FARGO BANK, NATIONAL ASSOCIATION SECURITY AGREEMENT Assignors: CONCEPTUS, INC.
Assigned to CONCEPTUS, INC. reassignment CONCEPTUS, INC. RELEASE BY SECURED PARTY (SEE DOCUMENT FOR DETAILS). Assignors: WELLS FARGO BANK, NATIONAL ASSOCIATION
Assigned to BAYER ESSURE INC. reassignment BAYER ESSURE INC. CHANGE OF NAME (SEE DOCUMENT FOR DETAILS). Assignors: CONCEPTUS, INC.
Assigned to BAYER HEALTHCARE LLC reassignment BAYER HEALTHCARE LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: BAYER ESSURE INC.
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12168Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
    • A61B17/12172Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12099Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/1214Coils or wires
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B17/12Surgical instruments, devices or methods, e.g. tourniquets for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels, umbilical cord
    • A61B17/12022Occluding by internal devices, e.g. balloons or releasable wires
    • A61B17/12131Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
    • A61B17/12159Solid plugs; being solid before insertion
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F6/00Contraceptive devices; Pessaries; Applicators therefor
    • A61F6/20Vas deferens occluders; Fallopian occluders
    • A61F6/22Vas deferens occluders; Fallopian occluders implantable in tubes
    • A61F6/225Vas deferens occluders; Fallopian occluders implantable in tubes transcervical
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00Surgical instruments, devices or methods, e.g. tourniquets
    • A61B2017/00535Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated
    • A61B2017/00557Surgical instruments, devices or methods, e.g. tourniquets pneumatically or hydraulically operated inflatable
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/30092Properties of materials and coating materials using shape memory or superelastic materials, e.g. nitinol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0014Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof using shape memory or superelastic materials, e.g. nitinol

Definitions

  • This invention relates to the field of occluding devices and the methods of using such devices, and more particularly to contraceptive and sterilization devices.
  • This invention is directed to a device for occluding a body lumen, generally comprising a tubular member, and a mesh member transversely disposed on the tubular member which is permeable to allow for tissue ingrowth.
  • the tissue ingrowth produces a tissue impregnated mesh which occludes the body lumen.
  • a presently preferred embodiment is a contraceptive or sterilization device for occluding a reproductive tract or lumen to prevent the passage of reproductive cells through the tract or lumen.
  • the occluding device of the invention can be used in the fallopian tubes of a female patient, or the vas deferens of a male patient.
  • the occluding device of the invention can be used in other body lumens or passageways.
  • the occluding device of the invention can be used to repair a cardiac malformation, known as a ventricular septal defect, in which a passageway is formed in the heart wall that separates the right and left ventricles of the heart allowing blood leakage between the two ventricles.
  • a cardiac malformation known as a ventricular septal defect
  • the occluding device of the invention is secured to the heart wall defining the septal defect, and ingrowth of the myocardium into the device mesh member occludes the passageway to thereby repair the defect.
  • atrial septal defects or other passageways in the heart and elsewhere in the body may be occluded using the device of the invention.
  • the tubular member has a first end, a second end, and a lumen extending therein.
  • the mesh member extends transversely on the tubular member, so that cellular invasion through the mesh member occludes the tubular member lumen and, consequently, the body lumen in which it is installed.
  • the mesh member is disposed within the lumen of the tubular member.
  • the transversely disposed mesh member may be outside of the tubular member lumen, as for example, where the mesh member comprises an end cap having a peripheral edge connected to an end of the tubular member.
  • the tissue impregnated mesh forms an occluding member with improved durability over synthetic occluders, which are more vulnerable to rupture or failure within the body due to their synthetic structures.
  • the occluding device is highly flexible which facilitates the introduction and retention of the device within the body lumen.
  • the mesh member comprises strands of a material woven or bundled into a permeable structure.
  • a permeable structure such as a metal, polymeric material, and organics such as animal tissues, and is preferably reactive to tissue so as to promote the tissue ingrowth into the mesh member.
  • the tubular member is at least in part expandable within the body lumen from a first configuration suitable for introduction into the body lumen to a second larger configuration to facilitate securing the expanded tubular member to at least a portion of a wall which defines the body lumen.
  • the tubular member has an open or lattice-like framework which allows for the growth of tissue through the openings of the lattice-like framework, so as to interconnect the tubular member and the wall of the body lumen.
  • the surface of the tubular member may be treated to promote the tissue ingrowth.
  • the occluding device of the invention may be advanced to the desired location within the body lumen by a suitable delivery system, such as a delivery catheter or a conventional balloon catheter similar to those used for delivering stents, aortic grafts and various types of prosthesis.
  • a suitable delivery system such as a delivery catheter or a conventional balloon catheter similar to those used for delivering stents, aortic grafts and various types of prosthesis.
  • the device is introduced and positioned within the region of the body lumen to be occluded with the tubular member in the first configuration with small transverse dimensions. Once in place, the tubular member is then expanded to the second configuration with transverse dimensions roughly corresponding to or slightly larger than the body lumen, so that the tubular member can be secured to the wall defining the body lumen.
  • the tubular member may be self expanding or expanded by mechanical devices or by inflation of the balloon of the balloon catheter. The tubular member will then remain in the open configuration implanted in the body lumen.
  • tissue ingrowth, or epithelialization through the open framework of the tubular member secures it to the wall defining the body lumen.
  • epithelialization through the mesh member occludes the body lumen.
  • Sufficient epithelialization to secure the device to the body wall and occlude the body lumen may take one or more weeks. While the term “epithelialization” is used herein, it should be understood that, depending on the body lumen, tissues such as endothelium or myocardium may be impregnating the device. Additionally, scar tissue formation may take place as well.
  • One presently preferred embodiment of the invention comprises a reversible contraceptive system which reversibly occludes the reproductive body lumen.
  • the tissue impregnated mesh may be reopened by any number of suitable means.
  • the occluding member may be partially or completely cut away using an atherectomy type catheter or laser to create a lumen, and then compressed using a balloon dilatation catheter similar to an angioplasty procedure.
  • a plug may be releasably secured to the mesh member, so that the plug may be detached from the tissue impregnated mesh member to reopen the lumen.
  • the contraceptive device of the invention can be left in place to effectively block the passageway until the patient wishes to reverse the procedure.
  • the contraceptive or sterilization device of the invention provides effective sterilization or contraception for both males and females due to the tissue impregnated mesh member which occludes the reproductive body lumen and which has excellent durability.
  • the device remains in place within the reproductive body lumen, and the tissue impregnated mesh member resists degradation or tearing, to thereby decrease the risk of failure of the device.
  • the implantation of the device can be performed in a single office visit, using minimally invasive and easily used devices such as hysteroscopes, catheters, guidewires, guiding catheters and the like.
  • FIG. 1 is an elevational view of one embodiment of the occluding device of the invention with the tubular member in a contracted configuration.
  • FIG. 2 is a transverse cross sectional view of the device shown in FIG. 1, taken along lines 2 - 2 .
  • FIG. 3 is an elevational view of the device of the invention shown in FIG. 1, in an expanded configuration.
  • FIG. 4 is a transverse cross sectional view of the device shown in FIG. 3, taken along lines 4 - 4 .
  • FIG. 5 is an elevational view of another embodiment of the occluding device of the invention having a mesh member comprising bundled strands intermittently spaced in a plurality of sections of the tubular member.
  • FIG. 6 is an elevational view of another embodiment of the occluding device of the invention having a mesh member comprising woven strands disposed at the first end of the tubular member.
  • FIG. 7 is a transverse view of the mesh member, shown in FIG. 6, comprising woven strands.
  • FIG. 8 is a longitudinal cross sectional view of the device shown in FIG. 6, epithelialized in a body lumen.
  • FIG. 9 is a transverse cross sectional view of the device shown in FIG. 8, taken along lines 9 - 9 .
  • FIG. 10 illustrates another embodiment of the occluding device having a mesh layer on an outer surface of the tubular member, within a body lumen.
  • FIG. 11 illustrates the device shown in FIG. 10 in an expanded configuration.
  • FIG. 12 is an elevational view, partially in section, of a delivery catheter useful in a method of the invention with a self-expanding occluding device of the invention.
  • FIG. 13 is an elevational view, partially in section, of a balloon catheter useful in a method of the invention.
  • FIG. 14 illustrates the male reproductive anatomy, and a contraceptive device embodying features of the invention, within the vas deferens.
  • FIG. 15 is an enlarged view of the expanded contraceptive device shown in FIG. 14.
  • FIG. 16 illustrates the female reproductive anatomy, and a contraceptive device embodying features of the invention, within a fallopian tube.
  • FIG. 17 illustrates the device on a balloon catheter within a reproductive tract or body lumen, with the tubular member in a contracted configuration.
  • FIG. 18 illustrates the device shown in FIG. 16 within circle 18 , with the device on a balloon catheter within the fallopian tube, with the tubular member in an expanded configuration.
  • FIG. 19 is an enlarged, partially in section view of the tubular member shown in FIG. 18 within circle 19 , illustrating the mesh member and mesh layer.
  • FIGS. 20 and 21 are elevational views of another embodiment of the tubular member comprising a slotted member, in closed and expanded configurations, respectively.
  • FIGS. 22 and 23 are elevational views of another embodiment of the tubular member comprising a coil, in closed and expanded configurations, respectively.
  • FIG. 24 is is a transverse cross sectional view of another embodiment of the invention, having a plug releasably secured to the mesh member.
  • FIG. 1 illustrates an occluding device 10 embodying features of the invention generally comprising a tubular member 11 having a first end 12 , a second end 13 , and a lumen 14 extending therein.
  • a mesh member 15 is transversely disposed on the tubular member.
  • occluding device 10 comprises a contraceptive or sterilization device for occluding a reproductive body lumen.
  • FIG. 3 illustrates the tubular member 11 shown in FIG. 1 in an open, relatively large dimension configuration.
  • FIG. 4 showing a transverse cross section of the tubular member shown in FIG. 3 taken along lines 4 - 4 , the mesh member expands so that it extends across the expanded lumen 14 of the tubular member 11 .
  • the tubular member 11 has an open, lattice-type structure facilitating epithelialization which secures the occluding member to the wall defining the body lumen.
  • tubular member 11 can be deformed to an expanded diameter, preferably equal to or slightly larger than the dimensions of the body lumen within which the contraceptive device 10 is to be disposed.
  • expanded transverse dimensions should be about 0 . 1 mm to about 5 mm.
  • the mesh member 15 is permeable to allow for tissue ingrowth.
  • the permeability of the mesh member 15 facilitates epithelialization, and the epithelialized mesh occludes the reproductive body lumen sufficiently to prevent the passage of reproductive cells therethrough.
  • the mesh member 15 comprises intertwined strands of a biocompatible material connected to the tubular member 11 .
  • the mesh member comprises bundled strands.
  • the mesh member comprises woven strands.
  • FIG. 7 is a transverse view of the device illustrated in FIG. 6, illustrating the woven strands forming the mesh member.
  • the mesh member 15 comprises intertwined strands of a biocompatible material connected to the tubular member 11 .
  • the mesh member comprises bundled strands.
  • the mesh member comprises woven strands.
  • FIG. 7 is a transverse view of the device illustrated in FIG. 6, illustrating the woven strands forming the mesh member.
  • the mesh member 15 comprises intertwined strands of a
  • the mesh member 15 extends along the length of the tubular member 11 from the first end 12 to the second end 13 thereof.
  • the mesh member 15 is disposed in a plurality of sections intermittently spaced along the length of the tubular member.
  • FIG. 6 illustrates another embodiment, in which the mesh member 15 is disposed at the first end of the tubular member 11 .
  • the mesh member comprises a single sheet of woven material, disposed in the lumen of the tubular member 11 .
  • a plurality of stacked woven mesh sheets may be provided, including sheets having different mesh sizes.
  • the mesh member 15 is within the lumen 14 of the tubular member.
  • the mesh member may be connected to the tubular member 11 by a variety of suitable means including adhesive, heat bonding, or solvent bonding.
  • FIG. 8 illustrates the embodiment of the contraceptive device 10 shown in FIG. 6, installed within the patient's body lumen 21 , with tissue ingrowth 22 within the walls of the tubular member 11 and within the mesh member 15 .
  • FIG. 9 illustrates a transverse cross section of the installed device 10 shown in FIG. 8 taken along lines 9 - 9 .
  • the mesh member 15 is an irritant, such as Dacron or Nylon, which promotes epithelialization. Additionally, the mesh member may be coated or otherwise impregnated with cell growth stimulators, hormones, and/or chemicals to enhance tissue impregnation.
  • the fibers used to form the mesh member 15 are generally about 0.00025 mm to about 0.25 mm in diameter. It would be obvious that a wide variety of mesh sizes which support epithelialization may be used.
  • the mesh member 15 mesh size is about 5 ⁇ m to about 0.05 mm, and preferably about 10 ⁇ m to about 15 ⁇ m.
  • mesh members having relatively large mesh sizes are coated with the epithelialization promoter agents.
  • a mesh layer 16 is provided along at least a section of the outer surface and/or the inner surface of the tubular member, to facilitate tissue epithelialization along the tubular member 11 and into the mesh member 15 .
  • the mesh layer 16 is disposed along the entire length of the outer surface of the tubular member 11 and transversely disposed at the first end 12 of the tubular member.
  • the mesh layer may be an integral extension of the mesh member 15 , or a separate member connected to or separate from the mesh member 15 .
  • the mesh layer 16 comprises woven or bundled strands of a, preferably, biocompatible material, which may be a single or a plurality of mesh sheets, as discussed above in connection with the mesh member 15 .
  • the mesh layer is permeable to allow for tissue ingrowth, and consequently, facilitates ingrowth within the mesh member 15 , as for example, in embodiments in which only a section of the tubular member is expanded into contact with a wall of the body lumen, as discussed below.
  • the tubular member 11 may be expanded in the body lumen using a balloon catheter, or alternatively, it may be self expanding.
  • the tubular member is preferably self expanding in the embodiment in which the mesh member 15 is disposed along the length of the tubular member, as in the embodiment illustrated in FIG. 1, or is disposed at least in part at the second end of the tubular member, as in the embodiment illustrated in FIG. 5.
  • FIG. 12 illustrates a delivery catheter 31 useful in the delivery of the device 10 having self expanding tubular member.
  • the delivery catheter 31 generally comprises an elongated shaft 32 having a lumen 33 extending therein.
  • the self expanding tubular member 11 may be deformed into the smaller diameter configuration within the lumen 33 of the delivery catheter, and expanded into the larger diameter configuration within the body lumen by longitudinally displacing the tubular member out the distal end of the delivery catheter to thereby remove the radially compressive force of the delivery catheter.
  • a pusher 34 slidably received within the lumen of the delivery catheter can be used to longitudinally displace the tubular member 11 out the distal end of the delivery catheter.
  • FIG. 13 illustrates a catheter 35 useful in the practice of the invention, which comprises an elongated shaft 36 having an inflation lumen 37 which is in fluid communication with inflatable member 38 mounted on a distal section of the catheter shaft, and adapter 39 on a proximal end of the catheter shaft.
  • the tubular member 11 is mounted on the inflatable member 38 , and preferably closely conforms to the diameter of the uninflated inflatable member 38 to facilitate introduction into the desired body lumen
  • the tubular member 11 may be deformed to facilitate mounting onto the inflatable member 38 , and is expanded by the inflatable member to an open expanded configuration within a body lumen.
  • a guidewire 40 within the catheter lumen may extend through the mesh member 15 , provided the guidewire has a relatively small diameter compared with the mesh size. For example, a conventional guidewire having a diameter of about 0.018 inch or less inch may typically be extended through the mesh member 15 without adversely effecting the mesh member 15 .
  • FIG. 14 illustrates the male reproductive anatomy, including the vas deferens 41 in which the contraceptive device 10 of the invention may be installed.
  • the expanded tubular member 11 within the vas deferens is illustrated in FIG. 15.
  • FIG. 16 illustrates the female reproductive anatomy, including the fallopian tubes 42 in which the contraceptive device 10 is installed.
  • the device 10 is shown mounted on the inflatable member 38 of the catheter 35 and positioned within the fallopian tube 42 .
  • the practice of the invention comprises the following general steps, with specific reference to the embodiment illustrated in FIG. 16 comprising a contraceptive device 10 for occluding fallopian tubes of a female patient.
  • the contraceptive device 10 comprising a tubular member 11 having a relatively small transverse dimension is mounted onto the exterior of balloon 38 of catheter 35 , as shown in FIG. 17, and the catheter 35 is advanced under fluoroscopic, hysteroscopic, or ultrasonic visualization until tubular member 11 is positioned within one of the female patient's fallopian tubes 42 .
  • Inflation fluid is introduced through adapter 39 to inflate inflatable member 38 .
  • inflation of balloon 38 expands tubular member 11 to an open configuration, lodging it in fallopian tube 42 .
  • a section of the tubular member 11 extending from the second end of the tubular member is expanded into contact with the wall defining the fallopian tube 42 .
  • at least about 1 ⁇ 3 of the tubular member is expanded into contact with the body lumen wall to securely attach the device 10 within the fallopian tube 42 .
  • the inflatable member 38 is deflated, and the catheter 35 is removed, leaving the expanded tubular member 11 implanted in body lumen 42 .
  • Another contraceptive device 10 is delivered to the patient's other fallopian tube and expanded therein in the same manner.
  • the tubular member 11 may be expanded into position within the vas deferens 41 of a male patient to provide male contraception using the same procedures.
  • the contraceptive device 10 may be self expanding as discussed above.
  • FIG. 19 illustrates an enlarged, partially in section, view of the first end of the tubular member 11 and mesh member 1 5 therein, shown in FIG. 18 within circle 19 .
  • the mesh layer 16 is on the inner and outer surface of the tubular member 11 . Over a period of a week or more epithelial cells lining the lumen will proliferate, growing around the open framework of tubular member 11 and within the mesh member 15 , as shown in FIGS. 8 and 9, thereby securing the expanded tubular member 11 to the wall defining the fallopian tube 42 , and occluding the fallopian tube 42 .
  • FIGS. 8 and 9 illustrates an enlarged, partially in section, view of the first end of the tubular member 11 and mesh member 1 5 therein, shown in FIG. 18 within circle 19 .
  • the mesh layer 16 is on the inner and outer surface of the tubular member 11 .
  • epithelial cells lining the lumen will proliferate, growing around the open framework of tubular member 11 and within the mesh member
  • epithelial cells cover the inner and outer surfaces of the tubular member, so that the tubular member is secured to the fallopian tube as an embedded, integral member therein.
  • the layer of epithelial tissue that forms within the lattice-like structure of the tubular member 11 and optional mesh layer 16 helps block and seal the lumen so as to prevent the passage of reproductive cells, eggs or sperm cells.
  • tubular member 11 may have a number of suitable configurations as shown in schematically in FIGS. 1 , 20 - 23 .
  • tubular member 11 comprises a braided tube of wire or ribbon.
  • FIGS. 20 and 21 illustrate another embodiment in which tubular member 11 comprises a length of metal tubing 52 , such as hypodermic tubing, having slots.
  • FIG. 20 illustrates tubular member 11 in its relatively small dimensioned configuration for introduction and advancement into the patient's body lumen, and FIG. 21 its larger, open configuration. The slots cut into the wall of the tubing allow expansion of the occluding member into the open configuration shown in FIG. 21.
  • tubular member 11 is a coil 53 of wire or ribbon. It is obvious that a variety of other suitable configurations may be used for tubular member 11 , such as a number of closed sinusoidal rings of wire or ribbon.
  • mechanical, adhesive or other anchoring means may be employed to secure the expanded tubular member to the vessel wall defining the body lumen.
  • a stent or prosthetic device to an aortic or arterial wall described in U.S. Pat. No. 4,140,126; U.S. Pat. No. 4,562,596 ; U.S. Pat. No. 4,577,631; U.S. Pat. No. 4,787,899; U.S. Pat. No. 5,104,399; U.S. Pat. No. 5,167,614; U.S. Pat. No. 5,275,622; U.S. Pat. No. 5,456,713; and U.S. Pat. No.
  • 5,489,295 may be used with the present invention to interconnect the wall defining the reproductive tract and the tubular member.
  • barbs or hooks 54 may be provided on the tubular member 11 .
  • the barbs or hooks become imbedded in the wall defining the body lumen as the tubular member is expanded.
  • Such anchoring members are especially preferred for use in the fallopian tubes of a female patient, in order to prevent the peristaltic action therein from dislodging the device before the epithelialization of the tubular member 11 .
  • the tubular member 11 is formed from metals such as stainless steel, superelastic or shape memory material such as a nickel-titanium (NiTi) alloy such as NITINOL, platinum, tantalum, gold, or rigid or semirigid biocompatible plastics.
  • the tubular member is a superelatic material, providing a controlled force on the body lumen during expansion of the tubular member.
  • the surface of the tubular member's 11 framework may be designed to facilitate epithelial growth, as by providing the tubular member with an open or lattice-like framework to promote epithelial growth into as well as around the member to ensure secure attachment to, and embodiment within the wall of the body lumen.
  • Suitable surface techniques include EDM machining, laser drilling, photo etching, sintering and the like. Additionally, increasing the surface area of the tubular member can also provide greater adhesion for the epithelial tissue. Suitable surface treatments include plasma etching, sand blasting, machining and other treatments to roughen the surface.
  • the device may be coated or seeded to spur epithelialization. For example, the device can be coated with a polymer having impregnated therein a drug, enzyme or protein for inducing or promoting epithelial tissue growth.
  • the device could be plated with or otherwise incorporate an inflammatory material to produce an inflammatory response in the tissue of the wall defining the body lumen, which further contributes to the obstruction of the lumen.
  • the mesh member or mesh layer may incorporate strands or particles of inflammatory material therein.
  • the inflammatory material comprises copper or copper alloy.
  • Other inflammatory materials, such as radioactive materials, may be suitable as well.
  • at least a part of the device, as for example the tubular member could be radioactive, emitting alpha, beta or gamma particles.
  • the occlusion of the lumen may be reversed simply by removing the tissue impregnated mesh, as by cutting away using conventional atherectomy devices or lasers.
  • a balloon catheter can be used to compress the occluding tissue ingrowth to open up the passageway.
  • a balloon catheter can be advanced within the body lumen until the balloon is within the lumen left by the cutting of the tissue impregnated mesh and then the balloon on a catheter is inflated to widen the opening.
  • the device 10 further includes a plug 55 releasably secured to the mesh member 15 .
  • the plug 55 is secured to the mesh member, as by fusion bonding, biocompatible adhesive, or mechanical connectors, so that the plug may be removed from the implanted device in order to reverse the occlusion of the body lumen by opening up a lumen in the mesh member.
  • a variety of suitable materials may be used to form the plug, including metals and plastics.
  • the plug may be coated or seeded to spur epithelization, or be formed at least in part of an inflammatory material to produce an inflammatory response as discussed above.
  • the plug extends along at least the length of the mesh member, and preferably extends beyond an end of the mesh member.
  • the device 10 may be used to occlude a variety of body lumens or passageways.
  • a mechanical expandable member such as described in U.S. Pat. No. 4,585,000, which is incorporated herein by reference, may be used to expand the tubular member within the reproductive tract to engage the wall thereof.
  • individual features of embodiments of the invention may be shown in some of the drawings and not in others, those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of one or more of the other embodiments.

Abstract

A device for occluding a body lumen, and particularly contraceptive or sterilization device for occluding a reproductive tract or lumen to prevent the passage of reproductive cells through the tract or lumen, generally comprising a tubular member, and a mesh member, transversely disposed on the tubular member lumen. The mesh member is permeable to allow for tissue ingrowth, which produces a tissue impregnated mesh occluding the body lumen. The occluding device of the invention can be used in the fallopian tubes of a female patient, the vas deferens of a male patient, or other body lumen.

Description

    FIELD OF INVENTION
  • This invention relates to the field of occluding devices and the methods of using such devices, and more particularly to contraceptive and sterilization devices. [0001]
  • BACKGROUND OF THE INVENTION
  • Conventional contraceptive strategies generally fall within three categories: physical barriers, drugs and surgery. While each have certain advantages, they also suffer from various drawbacks. Barriers such as condoms and diaphragms are subject to failure due to breakage and displacement. Drug strategies, such as the pill and Norplant™, which rely on artificially controlling hormone levels, suffer from known and unknown side-effects from prolonged use. Finally, surgical procedures, such as tubal ligation and vasectomy, involve the costs and attendant risks of surgery, and are frequently not reversible. Thus, there remains a need for a safe, effective method of contraception, particularly a non-surgical method which is reversible. [0002]
  • SUMMARY OF THE INVENTION
  • This invention is directed to a device for occluding a body lumen, generally comprising a tubular member, and a mesh member transversely disposed on the tubular member which is permeable to allow for tissue ingrowth. The tissue ingrowth produces a tissue impregnated mesh which occludes the body lumen. A presently preferred embodiment is a contraceptive or sterilization device for occluding a reproductive tract or lumen to prevent the passage of reproductive cells through the tract or lumen. For example, the occluding device of the invention can be used in the fallopian tubes of a female patient, or the vas deferens of a male patient. However, the occluding device of the invention can be used in other body lumens or passageways. For example, the occluding device of the invention can be used to repair a cardiac malformation, known as a ventricular septal defect, in which a passageway is formed in the heart wall that separates the right and left ventricles of the heart allowing blood leakage between the two ventricles. Thus, the occluding device of the invention is secured to the heart wall defining the septal defect, and ingrowth of the myocardium into the device mesh member occludes the passageway to thereby repair the defect. Similarly, atrial septal defects or other passageways in the heart and elsewhere in the body may be occluded using the device of the invention. [0003]
  • In accordance with the invention, the tubular member has a first end, a second end, and a lumen extending therein. The mesh member extends transversely on the tubular member, so that cellular invasion through the mesh member occludes the tubular member lumen and, consequently, the body lumen in which it is installed. In a presently preferred embodiment, the mesh member is disposed within the lumen of the tubular member. However, the transversely disposed mesh member may be outside of the tubular member lumen, as for example, where the mesh member comprises an end cap having a peripheral edge connected to an end of the tubular member. The tissue impregnated mesh forms an occluding member with improved durability over synthetic occluders, which are more vulnerable to rupture or failure within the body due to their synthetic structures. Moreover, the occluding device is highly flexible which facilitates the introduction and retention of the device within the body lumen. [0004]
  • In a presently preferred embodiment, the mesh member comprises strands of a material woven or bundled into a permeable structure. However, other suitable permeable structures may be used, including a porous membranal structure which allows for tissue ingrowth. The mesh member is formed from a biocompatible material, such as a metal, polymeric material, and organics such as animal tissues, and is preferably reactive to tissue so as to promote the tissue ingrowth into the mesh member. [0005]
  • Preferably, the tubular member is at least in part expandable within the body lumen from a first configuration suitable for introduction into the body lumen to a second larger configuration to facilitate securing the expanded tubular member to at least a portion of a wall which defines the body lumen. In one presently preferred embodiment, the tubular member has an open or lattice-like framework which allows for the growth of tissue through the openings of the lattice-like framework, so as to interconnect the tubular member and the wall of the body lumen. The surface of the tubular member may be treated to promote the tissue ingrowth. [0006]
  • The occluding device of the invention may be advanced to the desired location within the body lumen by a suitable delivery system, such as a delivery catheter or a conventional balloon catheter similar to those used for delivering stents, aortic grafts and various types of prosthesis. The device is introduced and positioned within the region of the body lumen to be occluded with the tubular member in the first configuration with small transverse dimensions. Once in place, the tubular member is then expanded to the second configuration with transverse dimensions roughly corresponding to or slightly larger than the body lumen, so that the tubular member can be secured to the wall defining the body lumen. The tubular member may be self expanding or expanded by mechanical devices or by inflation of the balloon of the balloon catheter. The tubular member will then remain in the open configuration implanted in the body lumen. [0007]
  • With the open, lattice-like framework of the tubular member expanded within the body lumen, tissue ingrowth, or epithelialization, through the open framework of the tubular member secures it to the wall defining the body lumen. At the same time, epithelialization through the mesh member occludes the body lumen. Sufficient epithelialization to secure the device to the body wall and occlude the body lumen may take one or more weeks. While the term “epithelialization” is used herein, it should be understood that, depending on the body lumen, tissues such as endothelium or myocardium may be impregnating the device. Additionally, scar tissue formation may take place as well. [0008]
  • One presently preferred embodiment of the invention comprises a reversible contraceptive system which reversibly occludes the reproductive body lumen. The tissue impregnated mesh may be reopened by any number of suitable means. For example, the occluding member may be partially or completely cut away using an atherectomy type catheter or laser to create a lumen, and then compressed using a balloon dilatation catheter similar to an angioplasty procedure. Alternatively, a plug may be releasably secured to the mesh member, so that the plug may be detached from the tissue impregnated mesh member to reopen the lumen. Thus, the contraceptive device of the invention can be left in place to effectively block the passageway until the patient wishes to reverse the procedure.[0009]
  • The contraceptive or sterilization device of the invention provides effective sterilization or contraception for both males and females due to the tissue impregnated mesh member which occludes the reproductive body lumen and which has excellent durability. The device remains in place within the reproductive body lumen, and the tissue impregnated mesh member resists degradation or tearing, to thereby decrease the risk of failure of the device. Moreover, the implantation of the device can be performed in a single office visit, using minimally invasive and easily used devices such as hysteroscopes, catheters, guidewires, guiding catheters and the like. These and other advantages of the invention will become more apparent from the following detailed description of the invention when taken in conjunction with the accompanying exemplary drawings. [0010]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIG. 1 is an elevational view of one embodiment of the occluding device of the invention with the tubular member in a contracted configuration. [0011]
  • FIG. 2 is a transverse cross sectional view of the device shown in FIG. 1, taken along lines [0012] 2-2.
  • FIG. 3 is an elevational view of the device of the invention shown in FIG. 1, in an expanded configuration. [0013]
  • FIG. 4 is a transverse cross sectional view of the device shown in FIG. 3, taken along lines [0014] 4-4.
  • FIG. 5 is an elevational view of another embodiment of the occluding device of the invention having a mesh member comprising bundled strands intermittently spaced in a plurality of sections of the tubular member. [0015]
  • FIG. 6 is an elevational view of another embodiment of the occluding device of the invention having a mesh member comprising woven strands disposed at the first end of the tubular member. [0016]
  • FIG. 7 is a transverse view of the mesh member, shown in FIG. 6, comprising woven strands. [0017]
  • FIG. 8 is a longitudinal cross sectional view of the device shown in FIG. 6, epithelialized in a body lumen. [0018]
  • FIG. 9 is a transverse cross sectional view of the device shown in FIG. 8, taken along lines [0019] 9-9.
  • FIG. 10 illustrates another embodiment of the occluding device having a mesh layer on an outer surface of the tubular member, within a body lumen. [0020]
  • FIG. 11 illustrates the device shown in FIG. 10 in an expanded configuration. [0021]
  • FIG. 12 is an elevational view, partially in section, of a delivery catheter useful in a method of the invention with a self-expanding occluding device of the invention. [0022]
  • FIG. 13 is an elevational view, partially in section, of a balloon catheter useful in a method of the invention. [0023]
  • FIG. 14 illustrates the male reproductive anatomy, and a contraceptive device embodying features of the invention, within the vas deferens. [0024]
  • FIG. 15 is an enlarged view of the expanded contraceptive device shown in FIG. 14. [0025]
  • FIG. 16 illustrates the female reproductive anatomy, and a contraceptive device embodying features of the invention, within a fallopian tube. [0026]
  • FIG. 17 illustrates the device on a balloon catheter within a reproductive tract or body lumen, with the tubular member in a contracted configuration. [0027]
  • FIG. 18 illustrates the device shown in FIG. 16 within [0028] circle 18, with the device on a balloon catheter within the fallopian tube, with the tubular member in an expanded configuration.
  • FIG. 19 is an enlarged, partially in section view of the tubular member shown in FIG. 18 within [0029] circle 19, illustrating the mesh member and mesh layer.
  • FIGS. 20 and 21 are elevational views of another embodiment of the tubular member comprising a slotted member, in closed and expanded configurations, respectively. [0030]
  • FIGS. 22 and 23 are elevational views of another embodiment of the tubular member comprising a coil, in closed and expanded configurations, respectively. [0031]
  • FIG. 24 is is a transverse cross sectional view of another embodiment of the invention, having a plug releasably secured to the mesh member.[0032]
  • DETAILED DESCRIPTION OF THE INVENTION
  • FIG. 1 illustrates an occluding [0033] device 10 embodying features of the invention generally comprising a tubular member 11 having a first end 12, a second end 13, and a lumen 14 extending therein. As best shown in FIG. 2, illustrating a transverse cross section of the tubular member shown in FIG. 1 taken along lines 2-2, a mesh member 15 is transversely disposed on the tubular member. In a presently preferred embodiment, occluding device 10 comprises a contraceptive or sterilization device for occluding a reproductive body lumen.
  • In the embodiment illustrated in FIGS. 1 and 2, the [0034] tubular member 11 is in its relatively small dimensioned configuration for introduction and advancement into the patient's body lumen. FIG. 3 illustrates the tubular member 11 shown in FIG. 1 in an open, relatively large dimension configuration. As illustrated in FIG. 4, showing a transverse cross section of the tubular member shown in FIG. 3 taken along lines 4-4, the mesh member expands so that it extends across the expanded lumen 14 of the tubular member 11. In this configuration the tubular member 11 has an open, lattice-type structure facilitating epithelialization which secures the occluding member to the wall defining the body lumen. Preferably, tubular member 11 can be deformed to an expanded diameter, preferably equal to or slightly larger than the dimensions of the body lumen within which the contraceptive device 10 is to be disposed. For disposition within a female patient's fallopian tubes the expanded transverse dimensions should be about 0.1 mm to about 5 mm.
  • The [0035] mesh member 15 is permeable to allow for tissue ingrowth. The permeability of the mesh member 15 facilitates epithelialization, and the epithelialized mesh occludes the reproductive body lumen sufficiently to prevent the passage of reproductive cells therethrough. In a presently preferred embodiment, the mesh member 15 comprises intertwined strands of a biocompatible material connected to the tubular member 11. In the embodiment illustrated in FIG. 1, the mesh member comprises bundled strands. In the embodiment illustrated in FIG. 6 the mesh member comprises woven strands. FIG. 7 is a transverse view of the device illustrated in FIG. 6, illustrating the woven strands forming the mesh member. However, the mesh member 15 may comprise a variety of suitable permeable structures which support epithelialization, as for example, where the mesh member comprises the walls of the tubular member 11 connected together to form a closed end of the tubular member (not shown).
  • In the embodiment illustrated in FIG. 1, the [0036] mesh member 15 extends along the length of the tubular member 11 from the first end 12 to the second end 13 thereof. In another embodiment, illustrated in FIG. 5, the mesh member 15 is disposed in a plurality of sections intermittently spaced along the length of the tubular member. FIG. 6 illustrates another embodiment, in which the mesh member 15 is disposed at the first end of the tubular member 11. In the embodiment illustrated in FIG. 6, the mesh member comprises a single sheet of woven material, disposed in the lumen of the tubular member 11. Alternatively, a plurality of stacked woven mesh sheets may be provided, including sheets having different mesh sizes. In the embodiments illustrated in FIGS. 1, 5 and 6, the mesh member 15 is within the lumen 14 of the tubular member. The mesh member may be connected to the tubular member 11 by a variety of suitable means including adhesive, heat bonding, or solvent bonding.
  • The [0037] tubular member 11, expanded within the body lumen to be occluded, epithelializes to secure the contraceptive device 10 within the body lumen, and tissue ingrowth in the mesh member 15 occludes the lumen of the tubular member and the body lumen. FIG. 8 illustrates the embodiment of the contraceptive device 10 shown in FIG. 6, installed within the patient's body lumen 21, with tissue ingrowth 22 within the walls of the tubular member 11 and within the mesh member 15. FIG. 9 illustrates a transverse cross section of the installed device 10 shown in FIG. 8 taken along lines 9-9.
  • A variety of materials may be used to form the [0038] mesh member 15, including plastics, polymers, metals, and treated animal tissues. In a presently preferred embodiment, the mesh member 15 is an irritant, such as Dacron or Nylon, which promotes epithelialization. Additionally, the mesh member may be coated or otherwise impregnated with cell growth stimulators, hormones, and/or chemicals to enhance tissue impregnation. The fibers used to form the mesh member 15 are generally about 0.00025 mm to about 0.25 mm in diameter. It would be obvious that a wide variety of mesh sizes which support epithelialization may be used. For example, in one embodiment the mesh member 15 mesh size is about 5 μm to about 0.05 mm, and preferably about 10 μm to about 15 μm. Preferably, mesh members having relatively large mesh sizes are coated with the epithelialization promoter agents.
  • In one embodiment, illustrated in FIG. 10, a [0039] mesh layer 16 is provided along at least a section of the outer surface and/or the inner surface of the tubular member, to facilitate tissue epithelialization along the tubular member 11 and into the mesh member 15. In the embodiment illustrated in FIG. 10, the mesh layer 16 is disposed along the entire length of the outer surface of the tubular member 11 and transversely disposed at the first end 12 of the tubular member. The mesh layer may be an integral extension of the mesh member 15, or a separate member connected to or separate from the mesh member 15. In a presently preferred embodiment, the mesh layer 16 comprises woven or bundled strands of a, preferably, biocompatible material, which may be a single or a plurality of mesh sheets, as discussed above in connection with the mesh member 15. The mesh layer is permeable to allow for tissue ingrowth, and consequently, facilitates ingrowth within the mesh member 15, as for example, in embodiments in which only a section of the tubular member is expanded into contact with a wall of the body lumen, as discussed below.
  • The [0040] tubular member 11 may be expanded in the body lumen using a balloon catheter, or alternatively, it may be self expanding. The tubular member is preferably self expanding in the embodiment in which the mesh member 15 is disposed along the length of the tubular member, as in the embodiment illustrated in FIG. 1, or is disposed at least in part at the second end of the tubular member, as in the embodiment illustrated in FIG. 5.
  • FIG. 12 illustrates a [0041] delivery catheter 31 useful in the delivery of the device 10 having self expanding tubular member. The delivery catheter 31 generally comprises an elongated shaft 32 having a lumen 33 extending therein. The self expanding tubular member 11 may be deformed into the smaller diameter configuration within the lumen 33 of the delivery catheter, and expanded into the larger diameter configuration within the body lumen by longitudinally displacing the tubular member out the distal end of the delivery catheter to thereby remove the radially compressive force of the delivery catheter. A pusher 34 slidably received within the lumen of the delivery catheter can be used to longitudinally displace the tubular member 11 out the distal end of the delivery catheter.
  • Similarly, in the embodiment illustrated in FIG. 6 in which the [0042] mesh member 15 is disposed primarily in the first end of the tubular member, the tubular member may be expanded using a balloon catheter inserted into the open second end of the tubular member. FIG. 13 illustrates a catheter 35 useful in the practice of the invention, which comprises an elongated shaft 36 having an inflation lumen 37 which is in fluid communication with inflatable member 38 mounted on a distal section of the catheter shaft, and adapter 39 on a proximal end of the catheter shaft. The tubular member 11 is mounted on the inflatable member 38, and preferably closely conforms to the diameter of the uninflated inflatable member 38 to facilitate introduction into the desired body lumen The tubular member 11 may be deformed to facilitate mounting onto the inflatable member 38, and is expanded by the inflatable member to an open expanded configuration within a body lumen. A guidewire 40 within the catheter lumen may extend through the mesh member 15, provided the guidewire has a relatively small diameter compared with the mesh size. For example, a conventional guidewire having a diameter of about 0.018 inch or less inch may typically be extended through the mesh member 15 without adversely effecting the mesh member 15.
  • FIG. 14 illustrates the male reproductive anatomy, including the vas deferens [0043] 41 in which the contraceptive device 10 of the invention may be installed. The expanded tubular member 11 within the vas deferens is illustrated in FIG. 15. FIG. 16 illustrates the female reproductive anatomy, including the fallopian tubes 42 in which the contraceptive device 10 is installed. In FIG. 16, the device 10 is shown mounted on the inflatable member 38 of the catheter 35 and positioned within the fallopian tube 42.
  • The practice of the invention comprises the following general steps, with specific reference to the embodiment illustrated in FIG. 16 comprising a [0044] contraceptive device 10 for occluding fallopian tubes of a female patient. The contraceptive device 10 comprising a tubular member 11 having a relatively small transverse dimension is mounted onto the exterior of balloon 38 of catheter 35, as shown in FIG. 17, and the catheter 35 is advanced under fluoroscopic, hysteroscopic, or ultrasonic visualization until tubular member 11 is positioned within one of the female patient's fallopian tubes 42. Inflation fluid is introduced through adapter 39 to inflate inflatable member 38. As shown in FIG. 18, inflation of balloon 38 expands tubular member 11 to an open configuration, lodging it in fallopian tube 42. In the embodiment illustrated in FIG. 18, a section of the tubular member 11 extending from the second end of the tubular member, is expanded into contact with the wall defining the fallopian tube 42. In a presently preferred embodiment, at least about ⅓ of the tubular member is expanded into contact with the body lumen wall to securely attach the device 10 within the fallopian tube 42. The inflatable member 38 is deflated, and the catheter 35 is removed, leaving the expanded tubular member 11 implanted in body lumen 42. Another contraceptive device 10 is delivered to the patient's other fallopian tube and expanded therein in the same manner. Similarly, the tubular member 11 may be expanded into position within the vas deferens 41 of a male patient to provide male contraception using the same procedures. Alternatively, the contraceptive device 10 may be self expanding as discussed above.
  • FIG. 19 illustrates an enlarged, partially in section, view of the first end of the [0045] tubular member 11 and mesh member 1 5 therein, shown in FIG. 18 within circle 19. In the embodiment illustrated in FIG. 19, the mesh layer 16 is on the inner and outer surface of the tubular member 11. Over a period of a week or more epithelial cells lining the lumen will proliferate, growing around the open framework of tubular member 11 and within the mesh member 15, as shown in FIGS. 8 and 9, thereby securing the expanded tubular member 11 to the wall defining the fallopian tube 42, and occluding the fallopian tube 42. In the embodiment illustrated in FIGS. 8 and 9, epithelial cells cover the inner and outer surfaces of the tubular member, so that the tubular member is secured to the fallopian tube as an embedded, integral member therein. The layer of epithelial tissue that forms within the lattice-like structure of the tubular member 11 and optional mesh layer 16 helps block and seal the lumen so as to prevent the passage of reproductive cells, eggs or sperm cells.
  • The tubular member may have a number of suitable configurations as shown in schematically in FIGS. [0046] 1, 20-23. In the embodiment illustrated in FIG. 1, tubular member 11 comprises a braided tube of wire or ribbon. FIGS. 20 and 21 illustrate another embodiment in which tubular member 11 comprises a length of metal tubing 52, such as hypodermic tubing, having slots. FIG. 20 illustrates tubular member 11 in its relatively small dimensioned configuration for introduction and advancement into the patient's body lumen, and FIG. 21 its larger, open configuration. The slots cut into the wall of the tubing allow expansion of the occluding member into the open configuration shown in FIG. 21. Likewise, in FIGS. 22 and 23, tubular member 11 is a coil 53 of wire or ribbon. It is obvious that a variety of other suitable configurations may be used for tubular member 11, such as a number of closed sinusoidal rings of wire or ribbon.
  • In still other embodiments, mechanical, adhesive or other anchoring means may be employed to secure the expanded tubular member to the vessel wall defining the body lumen. For example, the means to secure a stent or prosthetic device to an aortic or arterial wall described in U.S. Pat. No. 4,140,126; U.S. Pat. No. 4,562,596 ; U.S. Pat. No. 4,577,631; U.S. Pat. No. 4,787,899; U.S. Pat. No. 5,104,399; U.S. Pat. No. 5,167,614; U.S. Pat. No. 5,275,622; U.S. Pat. No. 5,456,713; and U.S. Pat. No. 5,489,295 may be used with the present invention to interconnect the wall defining the reproductive tract and the tubular member. These patents are incorporated herein in their entireties by reference. For example, barbs or hooks [0047] 54, as illustrated in FIG. 21, may be provided on the tubular member 11. The barbs or hooks become imbedded in the wall defining the body lumen as the tubular member is expanded. Such anchoring members are especially preferred for use in the fallopian tubes of a female patient, in order to prevent the peristaltic action therein from dislodging the device before the epithelialization of the tubular member 11.
  • The [0048] tubular member 11 is formed from metals such as stainless steel, superelastic or shape memory material such as a nickel-titanium (NiTi) alloy such as NITINOL, platinum, tantalum, gold, or rigid or semirigid biocompatible plastics. In a presently preferred embodiment, the tubular member is a superelatic material, providing a controlled force on the body lumen during expansion of the tubular member. The surface of the tubular member's 11 framework may be designed to facilitate epithelial growth, as by providing the tubular member with an open or lattice-like framework to promote epithelial growth into as well as around the member to ensure secure attachment to, and embodiment within the wall of the body lumen. Suitable surface techniques include EDM machining, laser drilling, photo etching, sintering and the like. Additionally, increasing the surface area of the tubular member can also provide greater adhesion for the epithelial tissue. Suitable surface treatments include plasma etching, sand blasting, machining and other treatments to roughen the surface. In other embodiments, the device may be coated or seeded to spur epithelialization. For example, the device can be coated with a polymer having impregnated therein a drug, enzyme or protein for inducing or promoting epithelial tissue growth. In yet another refinement, at least part of the device, as for example the tubular member or the mesh layer, could be plated with or otherwise incorporate an inflammatory material to produce an inflammatory response in the tissue of the wall defining the body lumen, which further contributes to the obstruction of the lumen. For example, the mesh member or mesh layer may incorporate strands or particles of inflammatory material therein. In one embodiment the inflammatory material comprises copper or copper alloy. Other inflammatory materials, such as radioactive materials, may be suitable as well. For example, at least a part of the device, as for example the tubular member, could be radioactive, emitting alpha, beta or gamma particles.
  • The occlusion of the lumen may be reversed simply by removing the tissue impregnated mesh, as by cutting away using conventional atherectomy devices or lasers. Additionally, a balloon catheter can be used to compress the occluding tissue ingrowth to open up the passageway. For example, if a passageway larger than the passageway cut into the tissue impregnated mesh is desired, a balloon catheter can be advanced within the body lumen until the balloon is within the lumen left by the cutting of the tissue impregnated mesh and then the balloon on a catheter is inflated to widen the opening. In an alternative embodiment illustrated in FIG. 24, the [0049] device 10 further includes a plug 55 releasably secured to the mesh member 15. The plug 55 is secured to the mesh member, as by fusion bonding, biocompatible adhesive, or mechanical connectors, so that the plug may be removed from the implanted device in order to reverse the occlusion of the body lumen by opening up a lumen in the mesh member. A variety of suitable materials may be used to form the plug, including metals and plastics. The plug may be coated or seeded to spur epithelization, or be formed at least in part of an inflammatory material to produce an inflammatory response as discussed above. The plug extends along at least the length of the mesh member, and preferably extends beyond an end of the mesh member.
  • Various modifications and improvements may be made to the present invention without departing from the scope thereof. For example, while the invention has been discussed primarily in terms of occluding a reproductive body lumen, the [0050] device 10 may be used to occlude a variety of body lumens or passageways. A mechanical expandable member such as described in U.S. Pat. No. 4,585,000, which is incorporated herein by reference, may be used to expand the tubular member within the reproductive tract to engage the wall thereof. Moreover, although individual features of embodiments of the invention may be shown in some of the drawings and not in others, those skilled in the art will recognize that individual features of one embodiment of the invention can be combined with any or all the features of one or more of the other embodiments.

Claims (42)

What is claimed is:
1. A device for occluding a body lumen or passageway, comprising:
a) a tubular member having a first end, a second end, and a lumen extending therein, which is at least in part expandable within the body lumen from a first configuration to a second larger configuration; and
b) a mesh member transversely disposed on the tubular member, which is permeable to allow for tissue ingrowth to thereby occlude the body lumen.
2. The device of claim 1 wherein the mesh member comprises woven strands of a biocompatible material connected to the tubular member.
3. The device of claim 1 wherein the mesh member comprises bundled strands of a biocompatible material connected to the tubular member.
4. The device of claim 1 wherein the mesh member is formed from a material selected from the group consisting of nylon, dacron, metal, polymeric material, and animal tissue.
5. The device of claim 1 further including a mesh layer longitudinally disposed along at least a section of at least one of an inner and an outer surface of the tubular member.
6. The device of claim 5 wherein the mesh layer is longitudinally disposed along substantially the entire length of at least one of the inner and the outer surface of the tubular member.
7. The device of claim 1 wherein the mesh member is disposed within the lumen of the tubular member along substantially the entire length of the tubular member.
8. The device of claim 1 wherein the mesh member is disposed within the lumen of the tubular member in a plurality of sections intermittently spaced along the length of the tubular member.
9. The device of claim 1 wherein the mesh member is disposed within the lumen of the tubular member at the first end of the tubular member.
10. The device of claim 9 including a mesh layer longitudinally disposed along at least a section of at least one of an inner and outer surface of the tubular member.
11. The device of claim 1 wherein the tubular member comprises a material selected from the group consisting of stainless steel, superelastic material, shape memory material, rigid plastics, semirigid plastics, metal, NiTi, tantalum, platinum, and gold.
12. The device of claim 1 wherein the tubular member further includes anchoring members configured to secure the expanded tubular member to a wall defining the body lumen.
13. The device of claim 1 wherein the tubular member expands from the first configuration to the second larger configuration by the release of a radially compressive force.
14. The device of claim 13 wherein the tubular member comprises a superelastic material.
15. The device of claim 9 wherein the tubular member second larger configuration comprises a radially expanded diameter increasing along at least a section thereof from the first end of the tubular member to the second end of the tubular member.
16. The device of claim 1 wherein the tubular member comprises a lattice-like framework.
17. The device of claim 16 wherein the lattice-like framework comprises a thin walled metallic tube having a pattern of cuts configured to allow the tubular member to be expanded to the large diameter configuration.
18. The device of claim 16 wherein the lattice-like framework comprises a braid of wire.
19. The device of claim 16 wherein the lattice-like framework comprises a helical coil of wire.
20. The device of claim 1 wherein the surface of the tubular member is configured to promote epithelialization.
21. The device of claim 1 coated at least in part with a compound to promote tissue cell growth.
22. The device of claim 1 further comprising a material capable of provoking an inflammatory response.
23. The device of claim 22 wherein the inflammatory material comprises copper or copper alloy.
24. The device of claim 22 wherein the inflammatory material comprises a radioactive material.
25. The device of claim 1 wherein the tubular member has an open-wall structure to facilitate the ingrowth of tissue cells thereby securing at least a section of the expanded portion of the tubular member to a wall portion of the body lumen.
26. The device of claim 1 further including a plug releasably secured to the mesh member.
27. The device of claim 26 wherein the plug is formed at least in part of a material capable of provoking an inflammatory response.
28. A contraceptive or sterilization device for occluding a reproductive body lumen to prevent the passage of reproductive cells therethrough, comprising:
a) a tubular member having a first end, a second end, and a lumen extending therein, which is at least in part expandable within the reproductive body lumen from a first configuration to a second larger configuration; and
b) a mesh member connected to the tubular member, which is permeable to allow for tissue ingrowth to thereby occlude the reproductive body lumen.
29. A contraceptive device installed within a lumen of the patient's reproductive system, comprising
a) a tubular member having a first end, a second end, and a lumen extending therein, and having at least a portion thereof which is secured to a body wall portion defining at least in part the lumen of the patient's reproductive system; and
b) an occluding member connected to the tubular member comprising an epithelialized mesh which occludes the lumen of the patient's reproductive system sufficiently to prevent the passage of reproductive cells therethrough.
30. The installed contraceptive device of the claim 29 wherein the tubular member is epithelialized along at least a length thereof.
31. A contraceptive system, comprising
a) a catheter having a proximal end, a distal end, and a lumen extending at least in part therein; and
b) a contraceptive device releasably connected to the catheter, having a tubular member having a first end, a second end, and a lumen extending therein, which is at least in part expandable within the reproductive body lumen from a first configuration to a second larger configuration, and having a mesh member connected to the tubular member, which is permeable to allow for tissue ingrowth to thereby occlude the reproductive body lumen.
32. The contraceptive system of claim 31 including an expanding member on a distal section of the catheter to expand at least a portion of the tubular member.
33. A method of contraception comprising the steps of:
a) inserting within a desired body lumen a contraceptive device comprising a tubular member and a mesh member connected thereto;
b) expanding the tubular member within the body lumen;
c) securing the expanded tubular member to a wall portion defining at least in part the body lumen; and
d) epithelializing the mesh member to occlude the body lumen.
34. The method of claim 33 wherein the step of securing the tubular member to the wall portion comprises epithelializing the tubular member within the body lumen.
35. The method of claim 34 wherein the contraceptive device further includes one or more connecting members on a surface of the tubular member, and wherein the step of securing the tubular member to the wall portion further comprises embedding the connecting members in the wall portion.
36. The method of claim 33 wherein the contraceptive device is disposed on an expandable member of a delivery catheter, and wherein the step of expanding the tubular member comprises inflating the expandable member.
37. The method of claim 36 wherein the mesh member of the contraceptive device is transversely disposed within a lumen of the tubular member at a first end of the tubular member, and a distal end of the expandable member of the catheter is disposed in the tubular member lumen proximal to the mesh member, and the step of inflating the expandable member expands the tubular member to a larger diameter increasing along at least a section of the tubular member from the second to the first end of the tubular member.
38. The method of claim 37 wherein at least the second end of the tubular member is expanded into contact with the wall portion of the body lumen.
39. The method of claim 38 further including the step of deflating the expandable member and withdrawing the delivery catheter from the body lumen.
40. The method of claim 33 wherein the step of expanding the tubular member comprises the step of releasing a radially compressive force on the tubular member.
41. The method of claim 40 wherein the contraceptive device is disposed within a lumen of a delivery catheter, and the step of releasing the radially compressive force comprises longitudinally displacing the tubular member out a distal end of the delivery catheter.
42. The method of claim 33 wherein the expanded tubular member is disposed within the body lumen for sufficient time for it to be epithelialized within the body lumen and thereby secured to the wall portion.
US09/468,749 1996-12-18 1999-12-21 Occluding device and method of use Expired - Lifetime US6432116B1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US09/468,749 US6432116B1 (en) 1996-12-18 1999-12-21 Occluding device and method of use
US09/911,551 US20010041900A1 (en) 1999-12-21 2001-07-23 Occluding device and method of use
US11/116,480 US20050217680A1 (en) 1996-12-18 2005-04-28 Occluding device and method of use

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/770,123 US7073504B2 (en) 1996-12-18 1996-12-18 Contraceptive system and method of use
US09/468,749 US6432116B1 (en) 1996-12-18 1999-12-21 Occluding device and method of use

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
US08/770,123 Continuation US7073504B2 (en) 1996-12-18 1996-12-18 Contraceptive system and method of use
US09/112,085 Continuation US6096052A (en) 1996-12-18 1998-07-08 Occluding device and method of use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/911,551 Continuation US20010041900A1 (en) 1996-12-18 2001-07-23 Occluding device and method of use

Publications (2)

Publication Number Publication Date
US20020029051A1 true US20020029051A1 (en) 2002-03-07
US6432116B1 US6432116B1 (en) 2002-08-13

Family

ID=25087554

Family Applications (6)

Application Number Title Priority Date Filing Date
US08/770,123 Expired - Fee Related US7073504B2 (en) 1996-12-18 1996-12-18 Contraceptive system and method of use
US09/468,749 Expired - Lifetime US6432116B1 (en) 1996-12-18 1999-12-21 Occluding device and method of use
US10/272,840 Abandoned US20030029457A1 (en) 1996-12-18 2002-10-16 Contraceptive system and method of use
US10/972,857 Expired - Fee Related US7398780B2 (en) 1996-12-18 2004-10-25 Contraceptive system and method of use
US12/035,219 Expired - Fee Related US8113205B2 (en) 1996-12-18 2008-02-21 Contraceptive system and method of use
US12/172,807 Expired - Fee Related US8707957B2 (en) 1996-12-18 2008-07-14 Contraceptive system and method of use

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US08/770,123 Expired - Fee Related US7073504B2 (en) 1996-12-18 1996-12-18 Contraceptive system and method of use

Family Applications After (4)

Application Number Title Priority Date Filing Date
US10/272,840 Abandoned US20030029457A1 (en) 1996-12-18 2002-10-16 Contraceptive system and method of use
US10/972,857 Expired - Fee Related US7398780B2 (en) 1996-12-18 2004-10-25 Contraceptive system and method of use
US12/035,219 Expired - Fee Related US8113205B2 (en) 1996-12-18 2008-02-21 Contraceptive system and method of use
US12/172,807 Expired - Fee Related US8707957B2 (en) 1996-12-18 2008-07-14 Contraceptive system and method of use

Country Status (10)

Country Link
US (6) US7073504B2 (en)
EP (3) EP0971658B1 (en)
JP (2) JP4394167B2 (en)
CN (1) CN1251510A (en)
AT (3) ATE339941T1 (en)
AU (1) AU726548B2 (en)
CA (1) CA2275503C (en)
DE (3) DE69736726T2 (en)
ES (2) ES2271727T3 (en)
WO (1) WO1998026737A1 (en)

Cited By (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254625A1 (en) * 2003-06-13 2004-12-16 Trivascular, Inc. Inflatable implant
WO2005074844A1 (en) * 2004-02-02 2005-08-18 Ams Research Corporation Contraceptive with permeable and impermeable components
WO2005074845A1 (en) * 2004-02-02 2005-08-18 Ams Research Corporation Enhancing tissue ingrowth for contraception
US20050187561A1 (en) * 2004-02-25 2005-08-25 Femasys, Inc. Methods and devices for conduit occlusion
US20050288551A1 (en) * 2004-04-28 2005-12-29 Ams Research Corporation Endoscopic delivery of medical devices
US20060052804A1 (en) * 2002-11-15 2006-03-09 Claude Mialhe Occlusive device for medical or surgical use
US20060052820A1 (en) * 2004-09-03 2006-03-09 Nancy Haig Reversible vessel seal
US20060058820A1 (en) * 2002-11-15 2006-03-16 Claude Mialhe Occlusive device for medical or surgical use
US7073504B2 (en) 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
US20060247614A1 (en) * 2005-04-28 2006-11-02 Sampson Russel M Hemostasis device
US20070056591A1 (en) * 2005-09-15 2007-03-15 Mcswain Hugh Fallopian tube occlusion devices and methods
JP2007521081A (en) * 2003-06-27 2007-08-02 エイエムエス・リサーチ・コーポレーション Method and apparatus for occlusion of body lumens and / or delivery of therapeutic agents
US20070227544A1 (en) * 2006-03-30 2007-10-04 Betsy Swann Methods and devices for deployment into a lumen
US20070244439A1 (en) * 2006-04-03 2007-10-18 Ams Research Corporation Linear Motion Delivery System for Female Sterilization Device
US20080051830A1 (en) * 2006-08-24 2008-02-28 Boston Scientific Scimed, Inc. Occluding device and method
US20080071269A1 (en) * 2006-09-18 2008-03-20 Cytyc Corporation Curved Endoscopic Medical Device
US20080071257A1 (en) * 2006-09-18 2008-03-20 Cytyc Corporation Power Ramping During RF Ablation
WO2008077123A1 (en) * 2006-12-19 2008-06-26 The Regents Of The University Of Colorado Shape memory polymer-based transcervical device for permanent or temporary sterilization
US20080302368A1 (en) * 2007-05-31 2008-12-11 Mcguckin Jr James F Fallopian tube occlusion device
US20090024155A1 (en) * 2004-02-25 2009-01-22 Kathy Lee-Sepsick Methods and Devices for Conduit Occlusion
US20090024108A1 (en) * 2004-02-25 2009-01-22 Kathy Lee-Sepsick Methods and Devices for Delivery of Compositions to Conduits
US20090062836A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Balloon assisted occlusion device
US20090062839A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Barbed stent vascular occlusion device
US20090062845A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Barrel occlusion device
US20090062838A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider device with occlusive barrier
US20090061136A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Apparatus and method for making a spider occlusion device
US20090062844A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider pfo closure device
US20090082803A1 (en) * 2007-09-26 2009-03-26 Aga Medical Corporation Braided vascular devices having no end clamps
US20090099596A1 (en) * 2007-05-31 2009-04-16 Rex Medical Closure device for left atrial appendage
US20090222037A1 (en) * 2008-03-03 2009-09-03 Bacoustics, Llc Ultrasonic vascular closure device
US20090240266A1 (en) * 2008-03-21 2009-09-24 Dennis William G Vessel Occlusion Clip and Application Thereof
US20100010393A1 (en) * 2008-07-08 2010-01-14 Medtronic Vascular, Inc. Treatment of Occlusions by External High Intensity Focused Ultrasound
US20100036372A1 (en) * 1996-04-12 2010-02-11 Csaba Truckai Moisture transport system for contact electrocoagulation
US20100086492A1 (en) * 2008-10-03 2010-04-08 Kathy Lee-Sepsick Methods and devices for sonographic imaging
US7731712B2 (en) 2004-12-20 2010-06-08 Cytyc Corporation Method and system for transcervical tubal occlusion
US7846160B2 (en) 2006-12-21 2010-12-07 Cytyc Corporation Method and apparatus for sterilization
US20110094519A1 (en) * 2009-10-23 2011-04-28 Vidya Gopal Contraceptive devices and methods
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8132566B2 (en) 2007-09-25 2012-03-13 Family Health International Vas deferens vasectomy capping device
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8551082B2 (en) 1998-05-08 2013-10-08 Cytyc Surgical Products Radio-frequency generator for powering an ablation device
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US20150105814A1 (en) * 2013-10-16 2015-04-16 Cook Medical Technologies Llc Vascular occluder with crossing frame elements
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US20190201233A1 (en) * 2017-12-29 2019-07-04 Gyrus Acmi, Inc. D.B.A. Olympus Surgical Technologies America Fallopian Tube BioCompatible Plug
US11000376B2 (en) * 2017-02-06 2021-05-11 C. R. Bard, Inc. Device and associated percutaneous minimally invasive method for creating a venous valve

Families Citing this family (167)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US20010041900A1 (en) * 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
EP1005296B8 (en) 1997-06-05 2005-06-08 Adiana, Inc. Apparatus for tubal occlusion
US9023031B2 (en) 1997-08-13 2015-05-05 Verathon Inc. Noninvasive devices, methods, and systems for modifying tissues
US6200312B1 (en) 1997-09-11 2001-03-13 Vnus Medical Technologies, Inc. Expandable vein ligator catheter having multiple electrode leads
DK1051116T3 (en) 1998-12-01 2009-02-02 Univ Washington Embolization device
US6309384B1 (en) 1999-02-01 2001-10-30 Adiana, Inc. Method and apparatus for tubal occlusion
US8702727B1 (en) 1999-02-01 2014-04-22 Hologic, Inc. Delivery catheter with implant ejection mechanism
US6709667B1 (en) 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
WO2001013832A1 (en) 1999-08-23 2001-03-01 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US6254631B1 (en) 1999-09-23 2001-07-03 Intratherapeutics, Inc. Stent with enhanced friction
WO2001066167A2 (en) * 2000-03-03 2001-09-13 Chuter Timothy A M Large vessel stents and occluders
US7306591B2 (en) 2000-10-02 2007-12-11 Novasys Medical, Inc. Apparatus and methods for treating female urinary incontinence
US6602272B2 (en) 2000-11-02 2003-08-05 Advanced Cardiovascular Systems, Inc. Devices configured from heat shaped, strain hardened nickel-titanium
US7976648B1 (en) 2000-11-02 2011-07-12 Abbott Cardiovascular Systems Inc. Heat treatment for cold worked nitinol to impart a shape setting capability without eventually developing stress-induced martensite
US7128757B2 (en) * 2000-12-27 2006-10-31 Advanced Cardiovascular, Inc. Radiopaque and MRI compatible nitinol alloys for medical devices
US6855161B2 (en) * 2000-12-27 2005-02-15 Advanced Cardiovascular Systems, Inc. Radiopaque nitinol alloys for medical devices
US20060086440A1 (en) * 2000-12-27 2006-04-27 Boylan John F Nitinol alloy design for improved mechanical stability and broader superelastic operating window
US6551341B2 (en) * 2001-06-14 2003-04-22 Advanced Cardiovascular Systems, Inc. Devices configured from strain hardened Ni Ti tubing
US8465516B2 (en) 2001-07-26 2013-06-18 Oregon Health Science University Bodily lumen closure apparatus and method
ATE294535T1 (en) * 2001-07-26 2005-05-15 Univ Oregon Health Sciences CLOSURE DEVICE FOR A VESSEL AND ATTACHMENT DEVICE
US7371258B2 (en) * 2001-10-26 2008-05-13 St. Jude Medical, Inc. Valved prosthesis with porous substrate
US6780182B2 (en) 2002-05-23 2004-08-24 Adiana, Inc. Catheter placement detection system and operator interface
US7087064B1 (en) 2002-10-15 2006-08-08 Advanced Cardiovascular Systems, Inc. Apparatuses and methods for heart valve repair
US7404824B1 (en) 2002-11-15 2008-07-29 Advanced Cardiovascular Systems, Inc. Valve aptation assist device
US8187324B2 (en) * 2002-11-15 2012-05-29 Advanced Cardiovascular Systems, Inc. Telescoping apparatus for delivering and adjusting a medical device in a vessel
US7981152B1 (en) 2004-12-10 2011-07-19 Advanced Cardiovascular Systems, Inc. Vascular delivery system for accessing and delivering devices into coronary sinus and other vascular sites
US7485143B2 (en) 2002-11-15 2009-02-03 Abbott Cardiovascular Systems Inc. Apparatuses and methods for heart valve repair
US7335213B1 (en) 2002-11-15 2008-02-26 Abbott Cardiovascular Systems Inc. Apparatus and methods for heart valve repair
US9149602B2 (en) 2005-04-22 2015-10-06 Advanced Cardiovascular Systems, Inc. Dual needle delivery system
WO2004058110A2 (en) * 2002-12-24 2004-07-15 Ovion, Inc. Contraceptive device and delivery system
US7942892B2 (en) 2003-05-01 2011-05-17 Abbott Cardiovascular Systems Inc. Radiopaque nitinol embolic protection frame
US20050061329A1 (en) * 2003-09-18 2005-03-24 Conceptus, Inc. Catheter for intrafallopian contraceptive delivery
US7998112B2 (en) 2003-09-30 2011-08-16 Abbott Cardiovascular Systems Inc. Deflectable catheter assembly and method of making same
US7901770B2 (en) * 2003-11-04 2011-03-08 Boston Scientific Scimed, Inc. Embolic compositions
US20050107867A1 (en) * 2003-11-17 2005-05-19 Taheri Syde A. Temporary absorbable venous occlusive stent and superficial vein treatment method
EP1686903B1 (en) * 2003-11-28 2014-07-30 Cook Medical Technologies LLC Vascular occlusion devices
EP1724556B1 (en) * 2004-03-09 2011-07-06 Denso Corporation Display device for vehicle
WO2005087140A1 (en) 2004-03-11 2005-09-22 Percutaneous Cardiovascular Solutions Pty Limited Percutaneous heart valve prosthesis
KR20070004750A (en) * 2004-03-25 2007-01-09 보오슈 앤드 롬 인코포레이팃드 Use of loteprednol etabonate for the treatment of dry eye
US7250050B2 (en) * 2004-06-07 2007-07-31 Ethicon, Inc. Tubal sterilization device having sesquipolar electrodes and method for performing sterilization using the same
US6964274B1 (en) 2004-06-07 2005-11-15 Ethicon, Inc. Tubal sterilization device having expanding electrodes and method for performing sterilization using the same
US7699056B2 (en) * 2004-06-10 2010-04-20 Conceptus, Inc. Medical devices and methods of making and using such devices
CA2575812C (en) 2004-08-02 2015-03-17 Merkechten En Patenten Nederland B.V. (M.P.N.) Device and method for treating a vessel
WO2006034153A2 (en) * 2004-09-17 2006-03-30 Cordis Neurovascular, Inc. Thin film metallic devices for plugging aneurysms or vessels
US7972354B2 (en) 2005-01-25 2011-07-05 Tyco Healthcare Group Lp Method and apparatus for impeding migration of an implanted occlusive structure
EP1845887A2 (en) * 2005-02-11 2007-10-24 Micardia Corporation Dynamically adjustable gastric implants and methods of treating obesity using dynamically adjustable gastric implants
US20060212113A1 (en) * 2005-02-24 2006-09-21 Shaolian Samuel M Externally adjustable endovascular graft implant
US20060206140A1 (en) * 2005-02-24 2006-09-14 Samuel Shaolian Adjustable embolic aneurysm coil
WO2006107901A1 (en) * 2005-04-04 2006-10-12 Micardia Corporation Dynamic reinforcement of the lower esophageal sphincter
US7963287B2 (en) 2005-04-28 2011-06-21 Boston Scientific Scimed, Inc. Tissue-treatment methods
US9463426B2 (en) 2005-06-24 2016-10-11 Boston Scientific Scimed, Inc. Methods and systems for coating particles
US7918863B2 (en) * 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
US20070050001A1 (en) * 2005-08-26 2007-03-01 Solarant Medical, Inc. Adjustable open loop control devices and methods
CA2629534C (en) 2005-11-10 2015-02-24 Arshad Quadri Balloon-expandable, self-expanding, vascular prosthesis connecting stent
US7867176B2 (en) * 2005-12-27 2011-01-11 Cordis Corporation Variable stiffness guidewire
US20080243068A1 (en) * 2005-12-29 2008-10-02 Kamal Ramzipoor Methods and apparatus for treatment of venous insufficiency
US20070161957A1 (en) * 2006-01-06 2007-07-12 Guenther Kevin V Hysteroscope Seal
US8961532B2 (en) * 2006-01-06 2015-02-24 Bayer Essure Inc. Atraumatic catheter tip
US20070208213A1 (en) * 2006-02-03 2007-09-06 Swann Susan E Method and apparatus for in-vitro fertilization and tubal occlusion
US7785317B2 (en) 2006-03-29 2010-08-31 Codman & Shurtleff, Inc. Joined metal tubing and method of manufacture
US9017361B2 (en) 2006-04-20 2015-04-28 Covidien Lp Occlusive implant and methods for hollow anatomical structure
US7975697B2 (en) 2006-05-11 2011-07-12 Conceptus, Inc. Methods and apparatus for occluding reproductive tracts to effect contraception
US8118859B2 (en) * 2006-05-26 2012-02-21 Codman & Shurtleff, Inc. Occlusion device combination of stent and mesh having offset parallelogram porosity
US8690938B2 (en) * 2006-05-26 2014-04-08 DePuy Synthes Products, LLC Occlusion device combination of stent and mesh with diamond-shaped porosity
US7766935B2 (en) * 2006-06-12 2010-08-03 Codman & Shurtleff, Inc. Modified headpiece for hydraulic coil deployment system
US7670353B2 (en) * 2006-06-12 2010-03-02 Codman & Shurtleff, Inc. Modified headpiece for hydraulic coil deployment system
US8585732B2 (en) * 2006-06-14 2013-11-19 DePuy Synthes Products, LLC Retrieval device with sidewall grippers
EP2043531B1 (en) 2006-06-15 2013-01-02 Cook Medical Technologies LLC Systems and devices for the delivery of endoluminal prostheses
US20080039828A1 (en) * 2006-08-10 2008-02-14 Jimenez Jose W Laser Tissue Vaporization
US8647349B2 (en) 2006-10-18 2014-02-11 Hologic, Inc. Systems for performing gynecological procedures with mechanical distension
TWI330950B (en) * 2006-10-27 2010-09-21 Sunplus Technology Co Ltd Sequential decoding method and apparatus thereof
US8025656B2 (en) * 2006-11-07 2011-09-27 Hologic, Inc. Methods, systems and devices for performing gynecological procedures
US9392935B2 (en) 2006-11-07 2016-07-19 Hologic, Inc. Methods for performing a medical procedure
US20090036840A1 (en) * 2006-11-22 2009-02-05 Cytyc Corporation Atraumatic ball tip and side wall opening
US8235048B2 (en) * 2006-12-01 2012-08-07 Rex Medical, L.P. Fallopian tube occlusion device
US8349099B1 (en) 2006-12-01 2013-01-08 Ormco Corporation Method of alloying reactive components
US20080140002A1 (en) * 2006-12-06 2008-06-12 Kamal Ramzipoor System for delivery of biologically active substances with actuating three dimensional surface
WO2008092028A1 (en) 2007-01-25 2008-07-31 Tini Alloy Company Frangible shape memory alloy fire sprinkler valve actuator
US8584767B2 (en) 2007-01-25 2013-11-19 Tini Alloy Company Sprinkler valve with active actuation
PL2124831T3 (en) 2007-03-15 2017-03-31 Ortho-Space Ltd. Prosthetic devices
WO2008115922A1 (en) 2007-03-19 2008-09-25 Michael Brenzel Methods and apparatus for occlusion of body lumens
EP2134283B1 (en) 2007-04-06 2014-06-11 Hologic, Inc. System and device for tissue removal
US20090270898A1 (en) * 2007-04-06 2009-10-29 Interlace Medical, Inc. Tissue removal device with high reciprocation rate
US9095366B2 (en) 2007-04-06 2015-08-04 Hologic, Inc. Tissue cutter with differential hardness
US9259233B2 (en) 2007-04-06 2016-02-16 Hologic, Inc. Method and device for distending a gynecological cavity
US9017362B2 (en) * 2007-06-13 2015-04-28 Cook Medical Technologies Llc Occluding device
US8007674B2 (en) * 2007-07-30 2011-08-30 Tini Alloy Company Method and devices for preventing restenosis in cardiovascular stents
US8100129B2 (en) 2007-08-28 2012-01-24 Conceptus, Inc. Methods and devices for occluding an ovarian pathway
US20090125023A1 (en) * 2007-11-13 2009-05-14 Cytyc Corporation Electrosurgical Instrument
WO2009073609A1 (en) 2007-11-30 2009-06-11 Tini Alloy Company Biocompatible copper-based single-crystal shape memory alloys
US7842143B2 (en) 2007-12-03 2010-11-30 Tini Alloy Company Hyperelastic shape setting devices and fabrication methods
US8382917B2 (en) 2007-12-03 2013-02-26 Ormco Corporation Hyperelastic shape setting devices and fabrication methods
WO2009086548A1 (en) * 2007-12-31 2009-07-09 C.R. Bard, Inc. Vascular graft prosthesis with selective flow reduction
US7987853B2 (en) 2008-04-25 2011-08-02 Conceptus, Inc. Devices and methods for occluding a fallopian tube
EP2299951B1 (en) 2008-05-16 2012-03-07 Conceptus, Inc. Occlusion device and system for occluding a reproductive body lumen
US20100006105A1 (en) * 2008-07-08 2010-01-14 Carter Phillip J Apparatus and methods for occluding a fallopian tube
US8322341B2 (en) 2008-09-09 2012-12-04 Conceptus, Inc. System and method for occluding a reproductive body lumen
CN102292053A (en) 2008-09-29 2011-12-21 卡迪尔克阀门技术公司 Heart valve
WO2010040009A1 (en) 2008-10-01 2010-04-08 Cardiaq Valve Technologies, Inc. Delivery system for vascular implant
US9427304B2 (en) * 2008-10-27 2016-08-30 St. Jude Medical, Cardiology Division, Inc. Multi-layer device with gap for treating a target site and associated method
US20100114151A1 (en) * 2008-10-27 2010-05-06 Mujwid James R Methods and devices for deployment into a lumen
US8356600B2 (en) * 2008-11-11 2013-01-22 Conceptus, Inc. Occlusion implant
WO2010071856A1 (en) * 2008-12-19 2010-06-24 Tyco Healthcare Group, L.P. Method and apparatus for storage and/or introduction of implant for hollow anatomical structure
US8347887B2 (en) 2008-12-23 2013-01-08 Ams Research Corporation Devices and methods for reversal of permanent sterilization
EP4119098A1 (en) 2009-04-15 2023-01-18 Edwards Lifesciences CardiAQ LLC Vascular implant and delivery system
US11903602B2 (en) 2009-04-29 2024-02-20 Hologic, Inc. Uterine fibroid tissue removal device
US8360065B2 (en) * 2009-05-21 2013-01-29 Boston Scientific Scimed, Inc. Occlusion of fallopian tubes in a vertebrate subject
US9730790B2 (en) 2009-09-29 2017-08-15 Edwards Lifesciences Cardiaq Llc Replacement valve and method
US20110144689A1 (en) * 2009-12-15 2011-06-16 Med Institute, Inc. Occlusion Device
CN102781377B (en) * 2009-12-21 2016-08-10 派特公司 Improvements to frameless intrauterine devices and systems
US8231619B2 (en) 2010-01-22 2012-07-31 Cytyc Corporation Sterilization device and method
WO2011110177A1 (en) 2010-03-09 2011-09-15 Lina Medical Aps Contraceptive device
US8550086B2 (en) 2010-05-04 2013-10-08 Hologic, Inc. Radiopaque implant
US8579964B2 (en) 2010-05-05 2013-11-12 Neovasc Inc. Transcatheter mitral valve prosthesis
EP2588042A4 (en) 2010-06-29 2015-03-18 Artventive Medical Group Inc Reducing flow through a tubular structure
US9247942B2 (en) 2010-06-29 2016-02-02 Artventive Medical Group, Inc. Reversible tubal contraceptive device
EP3459500B1 (en) 2010-09-23 2020-09-16 Edwards Lifesciences CardiAQ LLC Replacement heart valves and delivery devices
US9149277B2 (en) 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
US9375208B2 (en) 2010-12-30 2016-06-28 Covidien Lp Wound closure device
US20130019374A1 (en) 2011-01-04 2013-01-24 Schwartz Alan N Gel-based seals and fixation devices and associated systems and methods
US9521966B2 (en) 2012-05-17 2016-12-20 Alan N. Schwartz Localization of the parathyroid
US11045246B1 (en) 2011-01-04 2021-06-29 Alan N. Schwartz Apparatus for effecting feedback of vaginal cavity physiology
US9655557B2 (en) 2011-02-04 2017-05-23 Minerva Surgical, Inc. Methods and systems for evaluating the integrity of a uterine cavity
US8562623B2 (en) 2011-02-09 2013-10-22 ROSS ALAN McDONALD Vaginal occlusion device
WO2012138626A1 (en) * 2011-04-05 2012-10-11 Cook Medical Technologies Llc Fallopian tube filter
US9308087B2 (en) 2011-04-28 2016-04-12 Neovasc Tiara Inc. Sequentially deployed transcatheter mitral valve prosthesis
US9554897B2 (en) 2011-04-28 2017-01-31 Neovasc Tiara Inc. Methods and apparatus for engaging a valve prosthesis with tissue
US10716624B2 (en) 2011-05-05 2020-07-21 Biolitec Unternehmensbeteiligungs Ii Ag Minimally invasive contraception method and device
US9138343B2 (en) 2011-05-31 2015-09-22 Bayer Healthcare Llc Tip protector sleeve
EP2741676A1 (en) 2011-08-09 2014-06-18 Cook General Biotechnology LLC Vial useable in tissue extraction procedures
WO2013044166A1 (en) 2011-09-23 2013-03-28 Schwartz Alan N Non-invasive and minimally invasive and tightly targeted minimally invasive therapy methods and devices for parathyroid treatment
WO2013057566A2 (en) 2011-10-18 2013-04-25 Ortho-Space Ltd. Prosthetic devices and methods for using same
US9107737B2 (en) 2011-11-21 2015-08-18 Alan Schwartz Goggles with facial conforming eyepieces
US9060773B2 (en) * 2011-12-16 2015-06-23 Covidien Lp Occlusive implant delivery devices and associated methods
US9597223B2 (en) * 2012-05-23 2017-03-21 Nandhika Wijay Reversible acute occlusion implant, delivery catheter and method
US9345573B2 (en) 2012-05-30 2016-05-24 Neovasc Tiara Inc. Methods and apparatus for loading a prosthesis onto a delivery system
US10124197B2 (en) 2012-08-31 2018-11-13 TiNi Allot Company Fire sprinkler valve actuator
US11040230B2 (en) 2012-08-31 2021-06-22 Tini Alloy Company Fire sprinkler valve actuator
US8984733B2 (en) 2013-02-05 2015-03-24 Artventive Medical Group, Inc. Bodily lumen occlusion
US9095344B2 (en) 2013-02-05 2015-08-04 Artventive Medical Group, Inc. Methods and apparatuses for blood vessel occlusion
US10583002B2 (en) 2013-03-11 2020-03-10 Neovasc Tiara Inc. Prosthetic valve with anti-pivoting mechanism
US9730791B2 (en) 2013-03-14 2017-08-15 Edwards Lifesciences Cardiaq Llc Prosthesis for atraumatically grasping intralumenal tissue and methods of delivery
US9681951B2 (en) 2013-03-14 2017-06-20 Edwards Lifesciences Cardiaq Llc Prosthesis with outer skirt and anchors
US9572665B2 (en) 2013-04-04 2017-02-21 Neovasc Tiara Inc. Methods and apparatus for delivering a prosthetic valve to a beating heart
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737308B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9737306B2 (en) 2013-06-14 2017-08-22 Artventive Medical Group, Inc. Implantable luminal devices
USD755384S1 (en) * 2014-03-05 2016-05-03 Edwards Lifesciences Cardiaq Llc Stent
US9642624B2 (en) 2014-03-21 2017-05-09 Boston Scientific Scimed, Inc. Devices and methods for lumen occlusion
US10363043B2 (en) 2014-05-01 2019-07-30 Artventive Medical Group, Inc. Treatment of incompetent vessels
US10959761B2 (en) 2015-09-18 2021-03-30 Ortho-Space Ltd. Intramedullary fixated subacromial spacers
WO2017083753A1 (en) 2015-11-12 2017-05-18 Herr John C Compositions and methods for vas-occlusive contraception and reversal thereof
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US10350062B2 (en) 2016-07-21 2019-07-16 Edwards Lifesciences Corporation Replacement heart valve prosthesis
AU2018205258B2 (en) 2017-01-05 2023-08-24 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
US11045981B2 (en) 2017-01-30 2021-06-29 Ortho-Space Ltd. Processing machine and methods for processing dip-molded articles
CN110770138A (en) * 2017-04-24 2020-02-07 乔舒亚·D·莱文 Thixotropic Bingham plastic fluid contraception method
CA3078365A1 (en) * 2017-10-02 2019-04-11 Contraline, Inc. Methods and apparatus for delivering a stimulus to an occlusive implant
EP3716907B1 (en) 2017-12-01 2023-06-07 C. R. Bard, Inc. Adjustable vascular graft for custom inner diameter reduction and related methods
EP3720390A2 (en) 2018-01-25 2020-10-14 Edwards Lifesciences Corporation Delivery system for aided replacement valve recapture and repositioning post- deployment
US11318040B2 (en) 2018-11-13 2022-05-03 Contraline, Inc. Systems and methods for delivering biomaterials
CN109528319A (en) * 2018-12-29 2019-03-29 天津美电医疗科技有限公司 A kind of natural cavity protection sleeve pipe
WO2021245653A1 (en) * 2020-05-31 2021-12-09 Tel Hashomer Medical Research Infrastructure And Services Ltd. A fallopian tube retrievable device

Family Cites Families (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3334629A (en) * 1964-11-09 1967-08-08 Bertram D Cohn Occlusive device for inferior vena cava
US3687128A (en) 1970-02-25 1972-08-29 Garold H Williams Instant water heater
US3687129A (en) 1970-10-02 1972-08-29 Abcor Inc Contraceptive device and method of employing same
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3868956A (en) * 1972-06-05 1975-03-04 Ralph J Alfidi Vessel implantable appliance and method of implanting it
US3855996A (en) 1973-03-01 1974-12-24 Medtronic Inc Contraceptive apparatus and procedure
US3815578A (en) 1973-05-11 1974-06-11 Investors In Ventures Inc Method of inserting an implant into a portion of a tubular organ whose mucous lining has been partially removed
US4052754A (en) * 1975-08-14 1977-10-11 Homsy Charles A Implantable structure
US3991760A (en) * 1975-12-02 1976-11-16 The Procter & Gamble Company Vaginal medicament dispensing means
US4185618A (en) 1976-01-05 1980-01-29 Population Research, Inc. Promotion of fibrous tissue growth in fallopian tubes for female sterilization
US4140126A (en) * 1977-02-18 1979-02-20 Choudhury M Hasan Method for performing aneurysm repair
US4246896A (en) * 1978-10-30 1981-01-27 Dynatech Corp. Intracervical cuff (ICC) for contraception and prevention of venereal disease and applicator therefor
US4279252A (en) * 1979-08-24 1981-07-21 Martin Michael T X-ray scaling catheter
DE3038928A1 (en) 1980-10-15 1982-04-29 Waldemar Dr.Med. 6630 Saarlouis Bleier Expansion pessary for uterine tubes - with inner rigid core and outer soft elastic sleeve
US4657000A (en) * 1981-07-23 1987-04-14 Dynasplints Systems, Inc. Adjustable splint and securing means therefor
FR2522959A1 (en) 1982-03-15 1983-09-16 Hamou Jacques Tubular pessary for reversible pregnancy protection - has soft central tubular section with proximal and distal loop of fibrous material
US4638803A (en) 1982-09-30 1987-01-27 Rand Robert W Medical apparatus for inducing scar tissue formation in a body
AU1914583A (en) * 1982-09-30 1984-04-05 Hodgson, D.E. Expandable plug for tubular occlusion suitable for contraception
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US4585000A (en) 1983-09-28 1986-04-29 Cordis Corporation Expandable device for treating intravascular stenosis
US5190546A (en) 1983-10-14 1993-03-02 Raychem Corporation Medical devices incorporating SIM alloy elements
US5275622A (en) * 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US4787899A (en) * 1983-12-09 1988-11-29 Lazarus Harrison M Intraluminal graft device, system and method
US5104399A (en) * 1986-12-10 1992-04-14 Endovascular Technologies, Inc. Artificial graft and implantation method
US4562596A (en) * 1984-04-25 1986-01-07 Elliot Kornberg Aortic graft, device and method for performing an intraluminal abdominal aortic aneurysm repair
US4577631A (en) 1984-11-16 1986-03-25 Kreamer Jeffry W Aneurysm repair apparatus and method
US4606336A (en) * 1984-11-23 1986-08-19 Zeluff James W Method and apparatus for non-surgically sterilizing female reproductive organs
FR2573646B1 (en) * 1984-11-29 1988-11-25 Celsa Composants Electr Sa PERFECTED FILTER, PARTICULARLY FOR THE RETENTION OF BLOOD CLOTS
JPS62102757A (en) * 1985-10-30 1987-05-13 オリンパス光学工業株式会社 Oviduct closure jig
US4700701A (en) 1985-10-23 1987-10-20 Montaldi David H Sterilization method and apparatus
US4733665C2 (en) * 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US4964850A (en) * 1986-05-07 1990-10-23 Vincent Bouton Method for treating trans-nasal sinus afflictions using a double t-shaped trans-nasal aerator
US4834757A (en) * 1987-01-22 1989-05-30 Brantigan John W Prosthetic implant
US4869268A (en) * 1987-05-14 1989-09-26 Inbae Yoon Multi-functional instruments and stretchable ligating and occluding devices
US4969458A (en) * 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4922928A (en) * 1988-08-17 1990-05-08 Michael Burnhill Vaginal device
IT1227063B (en) * 1988-09-14 1991-03-14 Francesco Pianetti BIMETALLIC SPIRAL INTRAUTERINE DEVICE.
US4978358A (en) 1988-10-06 1990-12-18 Zimmer Inc. Orthopaedic prosthetic device possessing improved composite stem design
US4994069A (en) 1988-11-02 1991-02-19 Target Therapeutics Vaso-occlusion coil and method
FR2641692A1 (en) * 1989-01-17 1990-07-20 Nippon Zeon Co Plug for closing an opening for a medical application, and device for the closure plug making use thereof
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US5163958A (en) * 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
HU200905B (en) 1989-02-07 1990-09-28 Radelkis Electrokemiai Electrochemical contraceptive device
US5116318A (en) * 1989-06-06 1992-05-26 Cordis Corporation Dilatation balloon within an elastic sleeve
US5919202A (en) * 1989-12-05 1999-07-06 Yoon; Inbae Surgical instrument with jaws and movable internal needle and method for use thereof
US5439446A (en) * 1994-06-30 1995-08-08 Boston Scientific Corporation Stent and therapeutic delivery system
US5095917A (en) * 1990-01-19 1992-03-17 Vancaillie Thierry G Transuterine sterilization apparatus and method
CA2049973C (en) * 1990-02-28 2002-12-24 Rodney G. Wolff Intralumenal drug eluting prosthesis
US5354295A (en) 1990-03-13 1994-10-11 Target Therapeutics, Inc. In an endovascular electrolytically detachable wire and tip for the formation of thrombus in arteries, veins, aneurysms, vascular malformations and arteriovenous fistulas
CA2060067A1 (en) * 1991-01-28 1992-07-29 Lilip Lau Stent delivery system
US5108420A (en) * 1991-02-01 1992-04-28 Temple University Aperture occlusion device
CA2065634C (en) * 1991-04-11 1997-06-03 Alec A. Piplani Endovascular graft having bifurcation and apparatus and method for deploying the same
US5267945A (en) * 1991-04-24 1993-12-07 David Doctor Finger splint for treating pip joint injuries
US5197978B1 (en) 1991-04-26 1996-05-28 Advanced Coronary Tech Removable heat-recoverable tissue supporting device
US5147370A (en) * 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5474089A (en) 1991-06-26 1995-12-12 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method and device for reversible sterilization
US5226911A (en) 1991-10-02 1993-07-13 Target Therapeutics Vasoocclusion coil with attached fibrous element(s)
US5456713A (en) * 1991-10-25 1995-10-10 Cook Incorporated Expandable transluminal graft prosthesis for repairs of aneurysm and method for implanting
US5167614A (en) * 1991-10-29 1992-12-01 Medical Engineering Corporation Prostatic stent
US5176692A (en) * 1991-12-09 1993-01-05 Wilk Peter J Method and surgical instrument for repairing hernia
US5626605A (en) * 1991-12-30 1997-05-06 Scimed Life Systems, Inc. Thrombosis filter
JP2750646B2 (en) * 1992-07-16 1998-05-13 キヤノン株式会社 Display control device
US5303719A (en) 1992-08-14 1994-04-19 Wilk Peter J Surgical method and associated instrument assembly
US5382261A (en) 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5382259A (en) 1992-10-26 1995-01-17 Target Therapeutics, Inc. Vasoocclusion coil with attached tubular woven or braided fibrous covering
US5342348A (en) 1992-12-04 1994-08-30 Kaplan Aaron V Method and device for treating and enlarging body lumens
US5423849A (en) 1993-01-15 1995-06-13 Target Therapeutics, Inc. Vasoocclusion device containing radiopaque fibers
US5512051A (en) * 1993-02-16 1996-04-30 Boston Scientific Corporation Slip-layered catheter balloon
AU3886893A (en) 1993-04-23 1994-11-21 Bohdan Babinec Method, device and apparatus for reversible contraceptive sterilization
WO1994026175A1 (en) 1993-05-06 1994-11-24 Vitaphore Corporation Embolization device
US5487377A (en) * 1993-11-05 1996-01-30 Clinical Innovation Associates, Inc. Uterine manipulator and manipulator tip assembly
JP3185906B2 (en) * 1993-11-26 2001-07-11 ニプロ株式会社 Prosthesis for atrial septal defect
JPH07308388A (en) * 1994-05-18 1995-11-28 Nippon Zeon Co Ltd Ring-shaped balloon
US5499995C1 (en) 1994-05-25 2002-03-12 Paul S Teirstein Body passageway closure apparatus and method of use
US5545210A (en) 1994-09-22 1996-08-13 Advanced Coronary Technology, Inc. Method of implanting a permanent shape memory alloy stent
US5514176A (en) 1995-01-20 1996-05-07 Vance Products Inc. Pull apart coil stent
DE19508805C2 (en) 1995-03-06 2000-03-30 Lutz Freitag Stent for placement in a body tube with a flexible support structure made of at least two wires with different shape memory functions
US6143007A (en) * 1995-04-28 2000-11-07 Target Therapeutics, Inc. Method for making an occlusive device
US6176240B1 (en) * 1995-06-07 2001-01-23 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and their delivery
US6705323B1 (en) * 1995-06-07 2004-03-16 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices and methods
EP1366729B1 (en) 1995-06-07 2005-07-27 Conceptus, Inc. Contraceptive transcervical fallopian tube occlusion devices having mechanical fallopian tube attachment
US5542210A (en) * 1995-07-03 1996-08-06 Hupfl; Martin Apparatus for supporting plantlife growing in a ground area
US5743905A (en) * 1995-07-07 1998-04-28 Target Therapeutics, Inc. Partially insulated occlusion device
US5766203A (en) * 1995-07-20 1998-06-16 Intelliwire, Inc. Sheath with expandable distal extremity and balloon catheters and stents for use therewith and method
US5601600A (en) * 1995-09-08 1997-02-11 Conceptus, Inc. Endoluminal coil delivery system having a mechanical release mechanism
US6090063A (en) * 1995-12-01 2000-07-18 C. R. Bard, Inc. Device, system and method for implantation of filaments and particles in the body
US6270495B1 (en) * 1996-02-22 2001-08-07 Radiotherapeutics Corporation Method and device for enhancing vessel occlusion
US5669933A (en) * 1996-07-17 1997-09-23 Nitinol Medical Technologies, Inc. Removable embolus blood clot filter
US6096052A (en) * 1998-07-08 2000-08-01 Ovion, Inc. Occluding device and method of use
US7073504B2 (en) * 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
US20010041900A1 (en) * 1999-12-21 2001-11-15 Ovion, Inc. Occluding device and method of use
US5935137A (en) * 1997-07-18 1999-08-10 Gynecare, Inc. Tubular fallopian sterilization device
US6168633B1 (en) 1998-08-10 2001-01-02 Itzhak Shoher Composite surface composition for an implant structure
US6112747A (en) * 1998-11-06 2000-09-05 Jones; Jesse M. Method of sterilizing females
US6231589B1 (en) * 1999-03-22 2001-05-15 Microvena Corporation Body vessel filter
US6267776B1 (en) * 1999-05-03 2001-07-31 O'connell Paul T. Vena cava filter and method for treating pulmonary embolism
WO2001013832A1 (en) * 1999-08-23 2001-03-01 Conceptus, Inc. Insertion/deployment catheter system for intrafallopian contraception
US6709667B1 (en) * 1999-08-23 2004-03-23 Conceptus, Inc. Deployment actuation system for intrafallopian contraception
KR100337308B1 (en) 2000-08-21 2002-05-17 이계안 Bushing in suspension arm of vehicle
US20030066533A1 (en) * 2001-10-05 2003-04-10 Loy Randall A. Removable fallopian tube plug and associated methods

Cited By (118)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8506563B2 (en) 1996-04-12 2013-08-13 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US20100036372A1 (en) * 1996-04-12 2010-02-11 Csaba Truckai Moisture transport system for contact electrocoagulation
US9247989B2 (en) 1996-04-12 2016-02-02 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US9095348B2 (en) 1996-04-12 2015-08-04 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US8998898B2 (en) 1996-04-12 2015-04-07 Cytyc Surgical Products Moisture transport system for contact electrocoagulation
US8113205B2 (en) 1996-12-18 2012-02-14 Conceptus, Inc. Contraceptive system and method of use
US7073504B2 (en) 1996-12-18 2006-07-11 Ams Research Corporation Contraceptive system and method of use
US8707957B2 (en) 1996-12-18 2014-04-29 Bayer Essure Inc. Contraceptive system and method of use
US9554853B2 (en) 1998-05-08 2017-01-31 Hologic, Inc. Radio-frequency generator for powering an ablation device
US8551082B2 (en) 1998-05-08 2013-10-08 Cytyc Surgical Products Radio-frequency generator for powering an ablation device
US20060058820A1 (en) * 2002-11-15 2006-03-16 Claude Mialhe Occlusive device for medical or surgical use
US7445623B2 (en) * 2002-11-15 2008-11-04 Claude Mialhe Occlusive device for medical or surgical use
US7753925B2 (en) * 2002-11-15 2010-07-13 Claude Mialhe Occlusive device for medical or surgical use
US20060052804A1 (en) * 2002-11-15 2006-03-09 Claude Mialhe Occlusive device for medical or surgical use
US7632291B2 (en) 2003-06-13 2009-12-15 Trivascular2, Inc. Inflatable implant
US10201350B2 (en) 2003-06-13 2019-02-12 Trivascular, Inc. Inflatable implant
US20040254625A1 (en) * 2003-06-13 2004-12-16 Trivascular, Inc. Inflatable implant
US11000288B2 (en) 2003-06-13 2021-05-11 Trivascular, Inc. Inflatable implant
KR101200642B1 (en) * 2003-06-27 2012-11-12 콘셉투스 인코포레이티드 Methods and devices for occluding body lumens and/or for delivering therapeutic agents
JP2007521081A (en) * 2003-06-27 2007-08-02 エイエムエス・リサーチ・コーポレーション Method and apparatus for occlusion of body lumens and / or delivery of therapeutic agents
US20110208233A1 (en) * 2004-01-22 2011-08-25 Mcguckin Jr James F Device for preventing clot migration from left atrial appendage
AU2005209844B2 (en) * 2004-02-02 2010-07-08 Bayer Essure, Inc. Contraceptive with permeable and impermeable components
US9713549B2 (en) * 2004-02-02 2017-07-25 Bayer Healthcare Llc Contraceptive with permeable and impermeable components
US20060009798A1 (en) * 2004-02-02 2006-01-12 Ams Research Corporation Methods and devices for occluding body lumens and/or enhancing tissue ingrowth
US20050192616A1 (en) * 2004-02-02 2005-09-01 Callister Jeffrey P. Contraceptive with permeable and impermeable components
WO2005074845A1 (en) * 2004-02-02 2005-08-18 Ams Research Corporation Enhancing tissue ingrowth for contraception
WO2005074844A1 (en) * 2004-02-02 2005-08-18 Ams Research Corporation Contraceptive with permeable and impermeable components
US9308023B2 (en) 2004-02-25 2016-04-12 Femasys Inc. Methods and devices for conduit occlusion
US8316854B2 (en) 2004-02-25 2012-11-27 Femasys Inc. Methods and devices for conduit occlusion
US11779372B2 (en) 2004-02-25 2023-10-10 Femasys Inc. Methods and devices for conduit occlusion
US20050187561A1 (en) * 2004-02-25 2005-08-25 Femasys, Inc. Methods and devices for conduit occlusion
US8695606B2 (en) 2004-02-25 2014-04-15 Femasys Inc. Methods and devices for conduit occlusion
US9034053B2 (en) 2004-02-25 2015-05-19 Femasys Inc. Methods and devices for conduit occlusion
US8336552B2 (en) 2004-02-25 2012-12-25 Femasys Inc. Methods and devices for conduit occlusion
US20090024155A1 (en) * 2004-02-25 2009-01-22 Kathy Lee-Sepsick Methods and Devices for Conduit Occlusion
US8324193B2 (en) 2004-02-25 2012-12-04 Femasys Inc. Methods and devices for delivery of compositions to conduits
US10292732B2 (en) 2004-02-25 2019-05-21 Femasys, Inc. Methods and devices for conduit occlusion
US20090024108A1 (en) * 2004-02-25 2009-01-22 Kathy Lee-Sepsick Methods and Devices for Delivery of Compositions to Conduits
US20090277455A1 (en) * 2004-02-25 2009-11-12 Femasys Inc. Method and devices for conduit occlusion
US8316853B2 (en) * 2004-02-25 2012-11-27 Femasys Inc. Method and devices for conduit occlusion
US10111687B2 (en) 2004-02-25 2018-10-30 Femasys, Inc. Methods and devices for conduit occlusion
US9220880B2 (en) 2004-02-25 2015-12-29 Femasys Inc. Methods and devices for delivery of compositions to conduits
US9238127B2 (en) 2004-02-25 2016-01-19 Femasys Inc. Methods and devices for delivering to conduit
US9839444B2 (en) 2004-02-25 2017-12-12 Femasys Inc. Methods and devices for conduit occlusion
US8726906B2 (en) 2004-02-25 2014-05-20 Femasys Inc. Methods and devices for conduit occlusion
US9402762B2 (en) 2004-02-25 2016-08-02 Femasys Inc. Methods and devices for conduit occlusion
US8052669B2 (en) * 2004-02-25 2011-11-08 Femasys Inc. Methods and devices for delivery of compositions to conduits
US8048101B2 (en) * 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US8048086B2 (en) * 2004-02-25 2011-11-01 Femasys Inc. Methods and devices for conduit occlusion
US20100168514A1 (en) * 2004-04-28 2010-07-01 Callister Jeffrey P Endoscopic delivery of medical devices
US20050288551A1 (en) * 2004-04-28 2005-12-29 Ams Research Corporation Endoscopic delivery of medical devices
US20060052820A1 (en) * 2004-09-03 2006-03-09 Nancy Haig Reversible vessel seal
US8517027B2 (en) * 2004-09-03 2013-08-27 Boston Scientific Scimed, Inc. Reversible vessel seal
WO2006028679A1 (en) * 2004-09-03 2006-03-16 Boston Scientific Scimed, Inc. Reversible vessel seal
US7731712B2 (en) 2004-12-20 2010-06-08 Cytyc Corporation Method and system for transcervical tubal occlusion
US20060247614A1 (en) * 2005-04-28 2006-11-02 Sampson Russel M Hemostasis device
US7674260B2 (en) 2005-04-28 2010-03-09 Cytyc Corporation Emergency hemostasis device utilizing energy
US20070056591A1 (en) * 2005-09-15 2007-03-15 Mcswain Hugh Fallopian tube occlusion devices and methods
WO2007035316A3 (en) * 2005-09-15 2007-06-14 Hugh Mcswain Fallopian tube occlusion devices and methods
WO2007035316A2 (en) * 2005-09-15 2007-03-29 Hugh Mcswain Fallopian tube occlusion devices and methods
US20070227544A1 (en) * 2006-03-30 2007-10-04 Betsy Swann Methods and devices for deployment into a lumen
US8235047B2 (en) 2006-03-30 2012-08-07 Conceptus, Inc. Methods and devices for deployment into a lumen
US8707958B2 (en) 2006-03-30 2014-04-29 Bayer Essure Inc. Methods and devices for deployment into a lumen
US20070244439A1 (en) * 2006-04-03 2007-10-18 Ams Research Corporation Linear Motion Delivery System for Female Sterilization Device
US8562628B2 (en) 2006-04-03 2013-10-22 Conceptus, Inc. Linear motion delivery system for female sterilization device
US20080051830A1 (en) * 2006-08-24 2008-02-28 Boston Scientific Scimed, Inc. Occluding device and method
US20080071269A1 (en) * 2006-09-18 2008-03-20 Cytyc Corporation Curved Endoscopic Medical Device
US8486060B2 (en) 2006-09-18 2013-07-16 Cytyc Corporation Power ramping during RF ablation
US20080071257A1 (en) * 2006-09-18 2008-03-20 Cytyc Corporation Power Ramping During RF Ablation
WO2008077123A1 (en) * 2006-12-19 2008-06-26 The Regents Of The University Of Colorado Shape memory polymer-based transcervical device for permanent or temporary sterilization
US7846160B2 (en) 2006-12-21 2010-12-07 Cytyc Corporation Method and apparatus for sterilization
AU2008262587B2 (en) * 2007-05-31 2013-05-23 Rex Medical, L.P. Fallopian tube occlusion device
US20090099596A1 (en) * 2007-05-31 2009-04-16 Rex Medical Closure device for left atrial appendage
WO2008153653A1 (en) 2007-05-31 2008-12-18 Rex Medical, L.P. Fallopian tube occlusion device
US20080302368A1 (en) * 2007-05-31 2008-12-11 Mcguckin Jr James F Fallopian tube occlusion device
US7992565B2 (en) * 2007-05-31 2011-08-09 Rex Medical, L.P. Fallopian tube occlusion device
US20090061136A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Apparatus and method for making a spider occlusion device
US20090062844A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider pfo closure device
US8308752B2 (en) * 2007-08-27 2012-11-13 Cook Medical Technologies Llc Barrel occlusion device
US8025495B2 (en) 2007-08-27 2011-09-27 Cook Medical Technologies Llc Apparatus and method for making a spider occlusion device
US8734483B2 (en) 2007-08-27 2014-05-27 Cook Medical Technologies Llc Spider PFO closure device
US20090062838A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Spider device with occlusive barrier
US20090062845A1 (en) * 2007-08-27 2009-03-05 Cook Incorporated Barrel occlusion device
US20090062836A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Balloon assisted occlusion device
US20090062839A1 (en) * 2007-08-31 2009-03-05 Cook Incorporated Barbed stent vascular occlusion device
US8292907B2 (en) 2007-08-31 2012-10-23 Cook Medical Technologies Llc Balloon assisted occlusion device
US8132566B2 (en) 2007-09-25 2012-03-13 Family Health International Vas deferens vasectomy capping device
US8066755B2 (en) 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
US20090082803A1 (en) * 2007-09-26 2009-03-26 Aga Medical Corporation Braided vascular devices having no end clamps
US10433851B2 (en) 2007-09-26 2019-10-08 St. Jude Medical, Cardiology Division, Inc. Braided vascular devices having no end clamps
US8663309B2 (en) 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US10682222B2 (en) 2007-10-04 2020-06-16 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US10159557B2 (en) 2007-10-04 2018-12-25 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US8083789B2 (en) 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US20090222037A1 (en) * 2008-03-03 2009-09-03 Bacoustics, Llc Ultrasonic vascular closure device
US8241324B2 (en) * 2008-03-03 2012-08-14 Eilaz Babaev Ultrasonic vascular closure device
US8366726B2 (en) 2008-03-21 2013-02-05 Gyrx Llc Vessel occlusion clip and application thereof
US20090240266A1 (en) * 2008-03-21 2009-09-24 Dennis William G Vessel Occlusion Clip and Application Thereof
US20100010393A1 (en) * 2008-07-08 2010-01-14 Medtronic Vascular, Inc. Treatment of Occlusions by External High Intensity Focused Ultrasound
US10258375B2 (en) 2008-10-03 2019-04-16 Femasys, Inc. Methods and devices for sonographic imaging
US10172643B2 (en) 2008-10-03 2019-01-08 Femasys, Inc. Contrast agent generation and injection system for sonographic imaging
US20100086492A1 (en) * 2008-10-03 2010-04-08 Kathy Lee-Sepsick Methods and devices for sonographic imaging
US9554826B2 (en) 2008-10-03 2017-01-31 Femasys, Inc. Contrast agent injection system for sonographic imaging
US11648033B2 (en) 2008-10-03 2023-05-16 Femasys Inc. Methods and devices for sonographic imaging
US10070888B2 (en) 2008-10-03 2018-09-11 Femasys, Inc. Methods and devices for sonographic imaging
US11154326B2 (en) 2008-10-03 2021-10-26 Femasys Inc. Methods and devices for sonographic imaging
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US9421121B2 (en) 2009-10-23 2016-08-23 Bayer Healthcare Llc Contraceptive devices and methods
US20110094519A1 (en) * 2009-10-23 2011-04-28 Vidya Gopal Contraceptive devices and methods
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
US20150105814A1 (en) * 2013-10-16 2015-04-16 Cook Medical Technologies Llc Vascular occluder with crossing frame elements
US9844653B2 (en) * 2013-10-16 2017-12-19 Cook Medical Technologies Llc Vascular occluder with crossing frame elements
US11000376B2 (en) * 2017-02-06 2021-05-11 C. R. Bard, Inc. Device and associated percutaneous minimally invasive method for creating a venous valve
US11076982B2 (en) * 2017-12-29 2021-08-03 Gyrus Acmi, Inc. Fallopian biocompatible plug with differently expandable portions
US20190201233A1 (en) * 2017-12-29 2019-07-04 Gyrus Acmi, Inc. D.B.A. Olympus Surgical Technologies America Fallopian Tube BioCompatible Plug

Also Published As

Publication number Publication date
AU726548B2 (en) 2000-11-09
ES2219787T3 (en) 2004-12-01
DE69728566D1 (en) 2004-05-13
US7398780B2 (en) 2008-07-15
EP0971658B1 (en) 2004-04-07
EP1438939A3 (en) 2004-08-04
US20080308110A1 (en) 2008-12-18
DE69736726T2 (en) 2007-09-13
US7073504B2 (en) 2006-07-11
US20030029457A1 (en) 2003-02-13
ATE339941T1 (en) 2006-10-15
US8113205B2 (en) 2012-02-14
US20050081862A1 (en) 2005-04-21
JP4394167B2 (en) 2010-01-06
DE69737957T2 (en) 2008-04-17
US20020013589A1 (en) 2002-01-31
ATE263532T1 (en) 2004-04-15
DE69737957D1 (en) 2007-09-06
EP1438938A2 (en) 2004-07-21
CA2275503A1 (en) 1998-06-25
AU5703098A (en) 1998-07-15
EP0971658A1 (en) 2000-01-19
EP1438939A2 (en) 2004-07-21
WO1998026737A1 (en) 1998-06-25
CA2275503C (en) 2007-04-03
CN1251510A (en) 2000-04-26
US8707957B2 (en) 2014-04-29
US6432116B1 (en) 2002-08-13
ES2271727T3 (en) 2007-04-16
DE69736726D1 (en) 2006-11-02
ATE367779T1 (en) 2007-08-15
JP2008080141A (en) 2008-04-10
DE69728566T2 (en) 2005-03-24
EP1438938A3 (en) 2004-08-04
JP2002506359A (en) 2002-02-26
EP1438939B1 (en) 2007-07-25
EP1438938B1 (en) 2006-09-20
US20080135054A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
US6432116B1 (en) Occluding device and method of use
US6096052A (en) Occluding device and method of use
US20010041900A1 (en) Occluding device and method of use
AU2008229892B2 (en) Occluding device and method of use
CA2455464C (en) Aneurysm treatment device
EP1316293A2 (en) Aneurysm embolic device with an occlusive member
JP2009512515A (en) Methods and systems for clipping within a vessel and repairing intraluminal and tissue defects.
AU2002316320A1 (en) Aneurysm treatment device
JP2015083139A (en) Method and system for endovascularly clipping and repairing lumen and tissue defect
EP2376033B1 (en) Occlusion stent

Legal Events

Date Code Title Description
STCF Information on status: patent grant

Free format text: PATENTED CASE

CC Certificate of correction
AS Assignment

Owner name: AMS RESEARCH CORPORATION, MINNESOTA

Free format text: MERGER;ASSIGNOR:OVION, INC.;REEL/FRAME:017105/0615

Effective date: 20051012

FEPP Fee payment procedure

Free format text: PAT HOLDER NO LONGER CLAIMS SMALL ENTITY STATUS, ENTITY STATUS SET TO UNDISCOUNTED (ORIGINAL EVENT CODE: STOL); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

AS Assignment

Owner name: CONCEPTUS, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:023627/0861

Effective date: 20090930

Owner name: CONCEPTUS, INC.,CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:AMS RESEARCH CORPORATION;REEL/FRAME:023627/0861

Effective date: 20090930

FPAY Fee payment

Year of fee payment: 8

AS Assignment

Owner name: WELLS FARGO BANK, NATIONAL ASSOCIATION, CALIFORNIA

Free format text: SECURITY AGREEMENT;ASSIGNOR:CONCEPTUS, INC.;REEL/FRAME:026817/0493

Effective date: 20110825

AS Assignment

Owner name: CONCEPTUS, INC., CALIFORNIA

Free format text: RELEASE BY SECURED PARTY;ASSIGNOR:WELLS FARGO BANK, NATIONAL ASSOCIATION;REEL/FRAME:030249/0431

Effective date: 20130419

AS Assignment

Owner name: BAYER ESSURE INC., CALIFORNIA

Free format text: CHANGE OF NAME;ASSIGNOR:CONCEPTUS, INC.;REEL/FRAME:032075/0466

Effective date: 20131025

FPAY Fee payment

Year of fee payment: 12

AS Assignment

Owner name: BAYER HEALTHCARE LLC, NEW JERSEY

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BAYER ESSURE INC.;REEL/FRAME:036283/0050

Effective date: 20150711